Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ABRAXAS1	"ABRA1, ABRAXAS, CCDC98, FAM175A, FLJ13614"	ENSG00000163322	"Abraxas 1, BRCA1 A complex subunit"	Q6UWZ7	4	83459517-83523348	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Chromatin regulator"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 43.0;Endometrial stromal cells: 20.7;Proximal tubular cells: 30.1;Respiratory ciliated cells: 21.9;Theca cells: 26.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 36.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037654	Uncertain		Supported	"Nuclear bodies"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear bodies"		"HPA037654: AB_2675588"	"unprognostic (1.44e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.57e-3)"	"unprognostic (6.99e-2)"	"unprognostic (4.98e-4)"	"unprognostic (3.47e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.98e-2)"	"prognostic favorable (1.53e-4)"	"unprognostic (2.24e-3)"	"unprognostic (9.34e-3)"	"unprognostic (5.58e-2)"	"unprognostic (6.57e-2)"	4.4	3.9	2.9	3.9	2.0	7.9	3.8	7.7	3.0	5.1	12.0	3.3	3.7	6.4	2.1	5.2	4.8	5.7	3.7	2.4	1.4	4.1	2.2	3.8	8.0	2.2	2.2	14.8	3.4	2.2	1.1	2.9	2.4	2.7	2.8	3.6	3.5	2.2	6.4	5.7	3.1	2.9	0.5	4.1	3.6	10.8	2.6	4.8	7.4	2.0	3.8	3.8	3.5	5.1	5.6	3.4	6.8	8.2	6.1	25.2	3.6	4.1	5.1	1.9	2.9	7.6	9.0	22.1	3.3	4.3	4.2	2.9	3.7	2.9	3.5	8.8	2.4	12.9	4.6	9.1	4.9	15.3	11.1	10.9	2.5	2.7	2.4	10.2	8.7	12.9	36.7	13.2	4.7	3.7	17.2	5.6	11.5	6.3	5.0	9.3	7.6	5.5	4.2	4.6	6.3	5.1	5.3	2.2	9.6	5.5	6.3	6.3	11.5	7.4	7.6	7.4	6.0	11.5	8.4	16.1	6.7	12.8	5.3	4.0	2.5	2.1	2.0	2.3	2.6	2.1	3.5	2.4	1.9	3.3	5.4	4.2	3.2	5.0	2.3	1.5	3.2	1.9	2.9	2.0	7.7	3.0	2.4	1.4	2.2	2.2	2.4	0.5	2.6	5.1	14.3	16.0	12.4	0.0	4.6	0.0	0.0	0.0	0.0	0.0	11.4	13.0	0.0	0.0	8.6	12.9	0.0	5.2	8.8	0.0	43.0	9.2	0.0	11.9	20.7	5.7	0.0	0.0	0.0	6.5	6.9	9.1	0.0	5.9	6.3	12.3	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	7.2	0.0	0.0	0.0	0.0	7.4	0.0	0.0	1.7	0.0	0.0	30.1	21.9	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	2.9	6.2	26.8	0.0	0.0
ACD	"Pip1, Ptop, Tint1, Tpp1"	ENSG00000102977	"ACD shelterin complex subunit and telomerase recruitment factor"	Q96AP0	16	67657512-67660815	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease variant, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 71.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049411, HPA057660"	Approved		Enhanced	"Nuclear bodies"		NA	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear bodies"		"HPA049411: AB_2680752, HPA057660: AB_2683493"	"unprognostic (1.47e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.15e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.24e-3)"	"prognostic unfavorable (2.42e-6)"	"unprognostic (1.50e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.13e-3)"	"unprognostic (3.27e-2)"	"unprognostic (8.88e-2)"	"unprognostic (6.34e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.30e-1)"	13.0	9.9	14.2	7.3	14.4	10.1	12.9	14.4	17.7	17.1	12.0	14.8	4.2	16.4	4.0	9.1	15.6	5.2	11.2	14.6	14.2	10.8	6.7	9.9	10.1	14.6	14.2	19.9	12.4	6.3	13.7	4.7	15.0	12.2	2.3	2.7	9.4	6.3	9.8	11.4	12.1	4.6	14.1	14.9	11.2	23.7	14.6	5.5	10.0	3.2	5.6	15.5	12.2	14.6	42.1	32.3	18.4	19.2	8.3	5.8	39.5	17.1	11.3	25.0	30.3	42.0	20.3	11.6	19.4	9.4	22.5	32.7	11.3	32.8	8.2	12.6	37.4	24.9	13.4	42.4	5.8	32.5	37.6	8.3	10.0	33.7	17.7	9.4	15.9	34.3	15.7	8.1	12.6	45.2	31.8	31.8	23.5	16.3	21.5	44.1	19.8	48.0	10.5	16.6	26.3	23.1	64.0	6.7	14.5	5.3	15.8	17.9	13.8	26.6	22.4	31.9	26.1	21.7	28.6	35.9	24.7	20.5	23.3	34.5	18.2	22.8	40.2	22.2	34.1	46.4	36.7	34.8	21.0	37.7	28.5	30.3	25.9	43.5	25.8	22.9	39.5	24.7	14.2	14.4	14.4	17.7	14.6	14.2	14.6	14.2	15.0	14.1	14.6	14.6	19.4	6.4	11.9	5.5	22.3	14.4	15.9	22.6	21.6	14.7	13.7	16.0	2.8	8.6	12.6	11.0	4.2	25.1	22.5	5.5	9.8	21.3	59.3	6.6	7.7	15.4	12.5	11.6	6.2	19.6	22.8	14.1	9.7	6.8	27.9	13.6	12.8	4.7	15.5	13.5	6.1	6.4	6.1	7.6	20.6	71.4	15.2	13.4	23.2	4.7	19.3	14.3	30.9	4.0	3.6	18.4	9.2	11.7	17.0	9.9	10.2	13.2	16.1	10.8	6.6	11.8	14.8	58.1	24.1	7.1	9.7	11.4	27.0	6.9	9.0	10.0
ARHGEF19	"FLJ33962, WGEF"	ENSG00000142632	"Rho guanine nucleotide exchange factor 19"	Q8IW93	1	16197854-16212652	"Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 26.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 17.6;HaCaT: 14.4;T-47d: 25.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA068108			Approved	"Nuclear bodies"		No	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 6: T47d - Mammary gland"	"Cluster 33: Fibroblasts - ECM organization"	"Nuclear bodies"		"HPA068108: AB_2685956"	"unprognostic (2.19e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.74e-2)"	"unprognostic (9.45e-2)"	"prognostic favorable (6.53e-4)"	"unprognostic (4.01e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (8.88e-5)"	"unprognostic (3.72e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.80e-1)"	2.9	10.1	0.9	2.7	0.7	0.9	5.0	0.7	1.3	8.7	0.8	2.8	2.3	6.0	1.1	15.9	6.4	2.1	2.2	0.7	0.9	4.2	1.5	3.2	1.6	0.9	0.8	6.9	7.9	2.1	1.8	3.1	0.7	8.4	0.9	0.2	17.2	4.5	0.8	26.3	3.0	1.5	0.7	2.8	6.2	1.5	0.8	1.8	12.0	0.4	2.3	6.1	11.4	0.7	17.6	4.6	2.4	4.9	0.3	1.4	0.9	4.3	4.1	2.4	3.3	6.9	2.7	0.0	3.4	3.9	1.8	14.4	1.0	1.6	0.6	2.9	0.4	1.4	11.7	0.5	5.7	0.8	5.6	4.4	0.9	6.3	1.8	0.5	0.7	5.5	3.2	3.8	1.0	3.7	2.0	2.0	0.7	2.5	4.9	6.8	2.2	4.1	0.9	1.3	1.7	2.9	3.3	2.0	0.8	0.2	25.7	2.9	1.8	0.0	7.6	3.9	0.0	4.1	6.7	1.0	0.0	4.3	6.6	0.0	0.5	0.4	0.9	0.2	0.9	0.7	0.8	0.7	0.6	0.5	0.8	0.4	0.0	0.8	0.0	0.6	0.5	0.5	0.9	0.7	0.7	1.3	0.7	0.9	0.9	0.8	0.7	0.7	0.8	0.7	6.1	6.4	6.0	1.3	3.9	4.7	9.3	8.8	14.2	0.5	8.6	8.0	0.5	2.8	8.8	0.0	0.0	1.7	6.5	3.8	0.0	5.7	0.2	7.0	4.5	4.6	0.0	4.2	0.0	5.7	4.9	4.5	3.6	7.8	9.5	2.1	7.5	1.0	2.6	0.0	0.1	5.2	8.2	4.4	1.4	0.0	7.8	1.9	3.6	2.8	2.4	5.3	7.2	1.0	0.0	4.7	5.2	3.4	3.1	2.3	2.5	1.6	4.0	0.3	0.0	4.7	3.9	1.8	6.8	10.7	7.7	1.2	5.4	3.0	4.7	6.4
ATMIN	"ASCIZ, KIAA0431, ZNF822"	ENSG00000166454	"ATM interactor"	O43313	16	81035842-81047350	"Predicted intracellular proteins"	"DNA damage, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 180.6;Late spermatids: 288.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054967, HPA066900"	Approved		Supported	"Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nuclear bodies"		"HPA054967: AB_2682654, HPA066900: AB_2685744"	"unprognostic (9.92e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.32e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.48e-1)"	"unprognostic (4.26e-2)"	"prognostic favorable (6.80e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.60e-1)"	15.9	12.7	18.9	11.4	19.6	7.9	14.4	18.2	23.5	13.5	14.6	12.9	12.8	13.8	18.0	18.9	11.4	11.5	14.2	19.6	21.6	19.7	17.9	10.7	13.9	19.6	21.7	14.3	16.1	27.0	13.1	20.4	22.8	17.6	13.7	10.3	12.8	14.8	16.0	17.6	12.9	13.7	17.6	12.9	12.7	22.6	21.5	15.6	20.6	17.0	15.0	14.2	12.0	18.4	26.7	22.0	28.6	33.7	30.6	21.3	42.8	17.1	24.8	15.9	8.8	14.9	14.9	20.8	21.8	25.6	18.3	25.3	28.1	14.7	20.3	13.8	15.6	14.3	13.3	17.4	28.3	24.7	21.6	22.7	24.7	15.4	24.7	26.7	16.6	20.0	22.8	12.4	22.9	42.9	19.9	18.0	33.6	16.6	16.3	34.5	13.8	12.2	25.0	27.5	22.8	29.5	54.3	16.8	14.3	23.7	28.5	22.0	22.0	20.3	20.6	19.9	16.2	19.7	31.6	50.4	18.7	16.1	19.3	0.5	0.8	0.5	1.9	0.6	1.4	1.5	2.0	1.7	0.8	1.6	1.7	1.9	0.2	1.9	0.6	1.0	2.2	0.6	18.9	19.6	18.2	23.5	19.6	21.6	19.6	21.7	22.8	17.6	21.5	18.4	38.6	9.6	19.2	10.7	11.7	12.0	16.3	10.0	10.2	24.9	20.7	16.9	18.6	20.0	15.5	23.9	20.9	42.3	25.8	21.4	11.7	12.6	180.6	13.3	37.2	19.3	11.5	7.4	16.1	14.0	38.4	17.9	15.8	22.4	16.5	15.2	22.9	21.6	29.7	13.5	17.7	13.7	6.1	23.9	6.0	288.9	19.9	14.3	14.2	3.7	19.2	32.5	12.3	8.0	16.9	18.5	11.2	19.5	15.0	15.1	19.9	20.8	7.5	16.6	13.1	24.2	18.0	28.6	25.4	17.2	15.3	30.1	15.5	21.6	16.0	18.4
ATRX	"JMS, MRX52, RAD54, XH2, XNP"	ENSG00000085224	"ATRX chromatin remodeler"	P46100	X	77504880-77786233	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001906, CAB009372, HPA064684, CAB068176"	Supported		Supported	"Nuclear bodies"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	"Nuclear bodies"		"CAB009372: AB_2061023, CAB068176: AB_2665665, HPA001906: AB_1078249, HPA064684: AB_2685321"	"unprognostic (1.77e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.65e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.69e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.15e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.50e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.24e-1)"	18.0	15.9	17.3	17.6	20.4	29.9	18.1	32.9	20.4	18.0	21.4	12.7	11.2	21.2	14.8	13.3	11.8	14.7	15.5	19.2	19.8	16.9	13.2	13.4	22.6	15.0	20.1	24.9	13.4	23.2	8.5	16.6	16.6	19.2	13.5	26.8	14.0	14.8	19.1	15.6	10.9	15.6	16.4	22.8	16.5	6.6	22.6	25.7	20.0	26.9	18.6	14.1	9.9	19.7	36.0	55.1	60.1	45.0	31.8	38.1	21.2	29.4	27.3	21.8	25.9	19.6	30.7	48.5	29.9	32.5	39.9	30.0	44.6	18.1	37.5	27.3	30.8	29.3	67.2	16.2	16.1	38.4	10.2	25.5	20.2	32.2	30.4	29.4	41.9	30.3	34.9	53.3	29.3	27.6	30.2	25.0	42.0	17.6	42.5	48.6	76.3	26.0	25.6	46.4	33.1	55.5	60.5	23.1	21.9	37.2	18.6	20.8	55.8	32.8	76.1	34.4	21.0	16.3	52.9	42.1	23.0	30.9	27.8	44.0	10.5	22.7	26.0	13.3	25.2	31.2	24.0	20.9	8.1	32.4	24.6	20.1	33.2	23.2	20.0	20.7	22.2	9.7	17.3	20.4	32.9	20.4	19.2	19.8	15.0	20.1	16.6	16.4	22.6	19.7	201.0	160.3	230.1	157.4	176.6	92.4	112.2	71.3	114.9	220.1	87.8	86.7	277.8	60.1	101.5	71.7	212.7	72.2	176.9	49.0	23.5	91.8	4.7	103.1	195.5	162.8	126.8	105.8	197.8	83.1	51.0	134.3	114.2	137.3	113.1	261.4	97.8	56.7	70.9	158.2	246.9	78.0	69.2	87.0	101.6	12.7	162.4	113.1	62.2	195.8	149.0	112.3	183.4	202.5	237.1	92.0	47.6	208.0	183.9	120.8	49.2	37.2	102.6	245.4	92.1	174.7	160.0	19.8	52.8	78.7	84.4	59.8	158.0	312.4	73.3	112.0
BHLHE40	"BHLHB2, Clast5, DEC1, SHARP2, STRA13"	ENSG00000134107	"Basic helix-loop-helix family member e40"	O14503	3	4979437-4985323	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 386.7;granulocytes: 439.2;Squamous epithelial cells: 517.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 101.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 488.2;Karpas-707: 228.4;U-87 MG: 218.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028922	Uncertain		Supported	"Nuclear bodies"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nuclear bodies"		"HPA028922: AB_2672828"	"unprognostic (8.64e-3)"	"unprognostic (5.21e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.58e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.88e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (5.45e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.95e-2)"	"unprognostic (7.03e-3)"	154.1	99.0	38.5	52.9	38.4	188.2	200.0	36.1	48.7	141.6	41.4	67.9	30.8	67.6	34.6	353.2	61.5	100.4	153.4	38.1	32.8	151.4	187.9	112.1	52.4	52.0	47.5	76.0	79.8	67.5	92.6	72.2	39.3	98.1	47.4	118.3	117.3	32.5	251.7	207.2	42.6	65.2	40.5	26.9	43.5	14.1	49.6	40.6	82.7	46.8	50.7	172.1	272.3	37.0	40.4	53.4	0.1	14.7	30.8	23.8	78.6	7.5	19.7	7.7	30.2	3.4	39.7	0.2	19.6	14.2	118.9	31.5	6.6	108.0	13.2	488.2	4.7	9.8	39.6	11.9	29.7	25.5	192.8	55.1	63.3	88.9	25.4	53.4	30.0	1.7	53.9	228.4	20.3	28.4	3.9	10.8	2.9	45.6	87.1	0.7	17.6	23.0	74.4	7.9	0.8	1.7	132.6	34.2	40.0	45.9	78.6	38.8	39.7	30.4	29.3	28.9	50.0	175.9	82.8	1.6	218.0	19.8	15.3	101.4	9.7	54.5	24.7	4.9	24.9	7.7	13.1	16.6	15.2	4.5	2.9	10.1	14.3	54.9	0.5	19.9	0.9	11.9	38.5	38.4	36.1	48.7	38.1	32.8	52.0	47.5	39.3	40.5	49.6	37.0	172.5	67.3	191.3	32.3	24.9	165.4	112.8	330.5	373.3	15.4	136.6	74.7	65.0	40.0	297.7	46.0	0.0	32.0	159.8	52.9	11.7	75.2	0.3	210.2	69.6	161.6	10.7	2.5	36.6	72.5	89.3	102.6	68.3	386.7	439.2	0.5	75.0	56.5	38.3	10.1	4.5	32.6	136.3	52.1	354.0	1.7	7.2	117.9	108.5	27.2	42.9	95.1	44.3	11.1	3.3	138.8	37.9	3.8	38.0	61.1	8.8	23.1	102.1	11.5	6.6	55.3	94.4	0.2	0.4	517.2	262.0	158.4	97.8	0.3	24.4	129.4
BRD3	"KIAA0043, ORFX, RING3L"	ENSG00000169925	"Bromodomain containing 3"	Q15059	9	134030305-134068535	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Theca cells: 178.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051830	Approved		Approved	"Nuclear bodies"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear bodies"		"HPA051830: AB_2681627"	"unprognostic (3.53e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.20e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.98e-1)"	"prognostic favorable (2.71e-7)"	"unprognostic (1.00e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.42e-1)"	10.6	10.3	14.2	7.3	14.7	8.2	10.2	13.0	13.6	12.9	6.4	16.1	7.9	14.6	9.4	8.6	12.5	6.9	9.5	11.6	14.6	7.8	11.0	9.2	7.5	13.9	12.6	11.6	10.7	10.1	9.2	9.0	11.7	11.8	5.6	10.6	9.6	11.6	19.3	12.6	9.6	9.0	10.4	12.4	9.9	13.0	13.5	13.4	11.8	11.5	5.8	11.8	10.3	15.9	8.5	25.3	31.4	24.6	17.1	13.8	28.7	8.4	9.5	9.2	9.3	21.2	13.7	3.2	8.7	7.7	10.4	28.7	29.4	11.7	7.2	20.1	16.5	18.2	29.1	24.1	15.3	24.1	15.7	14.8	14.1	10.6	12.0	14.9	15.2	30.0	16.7	9.3	9.5	28.4	44.9	32.2	42.0	21.9	19.2	32.8	45.3	16.1	13.1	8.9	45.8	42.3	37.7	14.1	10.1	18.7	20.3	39.6	19.5	22.3	12.3	14.6	7.6	5.0	5.6	3.0	11.2	16.4	15.1	6.6	12.9	15.8	11.4	10.1	9.6	6.9	9.1	10.2	12.9	6.7	8.6	9.1	15.0	16.3	8.6	17.1	4.6	9.4	14.2	14.7	13.0	13.6	11.6	14.6	13.9	12.6	11.7	10.4	13.5	15.9	27.6	32.1	21.9	13.1	18.3	32.4	21.2	19.8	42.1	60.9	32.8	24.3	24.3	28.6	25.7	23.9	37.5	26.0	31.8	22.6	19.6	42.7	49.2	22.9	37.9	32.1	54.0	70.1	13.4	24.4	20.5	32.4	21.9	25.3	15.9	53.2	35.7	34.0	18.7	57.2	16.8	26.6	14.2	27.9	22.8	20.7	57.2	33.6	23.2	10.3	33.6	45.6	30.9	12.5	19.3	27.7	21.4	67.4	9.1	51.0	19.2	15.7	20.1	58.0	59.2	55.8	40.0	20.7	53.1	31.9	35.7	32.7	26.4	178.7	30.8	22.3
C12orf4		ENSG00000047621	"Chromosome 12 open reading frame 4"	Q9NQ89	12	4487735-4538508	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037871	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nuclear bodies"		"HPA037871: AB_10670531"	"unprognostic (5.88e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.07e-2)"	"unprognostic (6.69e-2)"	"unprognostic (2.96e-3)"	"unprognostic (8.59e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.26e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.92e-1)"	7.5	5.4	6.6	8.9	7.6	9.2	7.3	7.7	9.1	6.6	5.6	7.0	4.3	6.6	5.3	7.1	5.5	6.5	7.4	7.8	6.0	6.0	5.9	6.7	10.1	5.6	6.3	5.3	4.7	6.2	4.7	9.6	6.0	7.4	8.1	10.0	4.9	6.6	10.5	5.9	5.1	9.4	5.9	7.9	5.7	9.2	7.0	9.2	7.9	10.8	10.2	8.6	5.0	7.6	14.6	11.0	13.4	15.9	13.1	19.5	28.4	27.6	11.4	24.9	30.3	19.5	11.8	12.4	5.6	17.9	20.5	10.6	19.0	15.9	33.6	37.1	13.0	21.5	10.3	9.6	19.0	18.7	19.4	17.4	8.8	29.9	33.4	15.6	14.4	15.1	12.8	20.9	23.5	7.0	14.9	7.9	19.8	12.6	10.4	16.0	21.1	7.9	15.3	15.1	5.3	10.4	18.9	13.6	11.9	36.4	5.7	15.9	15.0	21.6	19.9	23.8	29.3	4.8	6.8	30.2	16.0	15.1	20.4	0.0	7.5	2.8	4.2	12.7	4.6	4.7	4.1	4.3	6.6	5.2	4.5	4.0	2.4	4.4	15.1	6.9	6.9	4.3	6.6	7.6	7.7	9.1	7.8	6.0	5.6	6.3	6.0	5.9	7.0	7.6	9.8	16.0	12.0	21.5	9.2	2.9	3.0	5.5	7.4	11.8	5.2	5.3	14.3	2.8	8.9	3.7	29.2	7.4	11.4	5.2	3.9	7.6	40.9	7.3	11.8	8.2	6.0	16.0	43.0	8.2	8.5	8.1	1.5	4.4	1.3	9.7	7.5	5.4	28.2	8.4	32.4	5.3	4.1	13.3	4.7	29.9	8.1	11.4	1.8	30.0	8.5	6.8	8.2	32.6	39.2	8.3	3.2	6.8	15.5	2.2	4.6	5.4	8.6	12.3	6.6	9.7	9.6	22.0	16.2	6.4	3.3	6.2	8.2	8.0	6.0	1.9
C8orf58	FLJ34715	ENSG00000241852	"Chromosome 8 open reading frame 58"	Q8NAV2	8	22599599-22604150	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 28.1;Extravillous trophoblasts: 30.4;Sertoli cells: 26.3;Syncytiotrophoblasts: 55.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA024667, HPA028286"	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 12: NES - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nuclear bodies"		"HPA024667: AB_1845783, HPA028286: AB_1845784"	"unprognostic (8.88e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.69e-2)"	"unprognostic (6.72e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.70e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.58e-6)"	"unprognostic (1.67e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.20e-2)"	11.1	7.1	8.8	4.3	8.3	4.5	10.8	13.5	9.9	10.6	8.5	7.7	3.5	9.2	4.9	9.8	8.9	7.2	9.9	8.4	8.9	13.3	7.9	10.6	5.5	9.5	8.4	9.3	6.2	4.9	5.5	16.6	8.9	8.3	3.2	5.9	7.1	5.5	9.0	13.6	7.2	4.8	8.7	25.7	6.3	16.5	8.9	3.5	8.1	4.8	3.5	8.6	9.9	8.6	7.7	11.4	30.8	18.2	8.3	9.5	8.4	16.9	14.2	20.9	15.0	2.2	6.4	1.5	8.0	18.7	14.2	7.5	5.6	15.9	13.4	2.3	2.6	4.5	12.0	1.2	14.5	1.6	6.7	13.7	13.5	12.4	7.8	18.7	12.2	5.9	2.8	2.2	16.8	5.5	3.4	8.4	18.8	6.3	7.5	5.6	7.7	1.8	12.8	7.0	3.2	10.0	8.3	5.9	20.0	31.8	5.6	3.6	17.0	22.7	18.1	15.9	15.7	2.7	1.8	1.5	11.7	3.3	18.6	0.0	0.2	1.2	0.1	0.5	0.1	0.4	0.1	0.3	0.1	0.4	0.6	0.5	0.0	0.0	0.0	0.1	0.0	0.1	8.8	8.3	13.5	9.9	8.4	8.9	9.5	8.4	8.9	8.7	8.9	8.6	9.8	3.2	2.0	3.9	5.0	10.3	3.8	7.0	2.8	2.9	4.2	5.0	2.4	0.0	4.9	0.0	0.0	28.1	3.6	3.4	0.0	11.5	1.2	1.4	6.4	12.1	4.2	0.8	1.0	6.7	30.4	6.1	2.0	3.2	1.3	5.4	15.7	0.8	9.5	1.7	1.1	1.7	6.1	3.1	5.4	2.3	8.7	2.9	3.6	1.9	7.9	6.5	1.0	1.0	0.3	12.5	3.3	6.4	2.8	5.1	3.9	2.3	2.4	4.8	26.3	3.1	6.7	1.8	2.9	4.1	9.7	55.8	3.8	4.6	2.2	2.8
CLIC3		ENSG00000169583	"Chloride intracellular channel 3"	O95833	9	136994608-136996568	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 317.0;skin 1: 122.0;thyroid gland: 109.6;vagina: 132.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 811.8;dendritic cells: 456.0;Extravillous trophoblasts: 1219.2;NK-cells: 541.7;Syncytiotrophoblasts: 2039.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 130.8"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	9	"plasmacytoid DC: 2635.7"	"Lineage enriched"	"Detected in all"	9	"dendritic cells: 2635.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 350.3;MCF7: 168.1;SK-BR-3: 65.0;T-47d: 147.2;TIME: 118.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005963	Enhanced		Supported	"Nuclear bodies"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nuclear bodies"		"HPA005963: AB_1078536"	"unprognostic (4.30e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.42e-3)"	"unprognostic (1.85e-1)"	"unprognostic (6.79e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.26e-3)"	"unprognostic (7.73e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (1.95e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (7.74e-4)"	8.6	0.6	0.9	1.3	1.0	4.0	2.6	1.3	1.6	75.0	1.4	1.3	0.3	1.8	4.6	317.0	1.7	0.8	8.6	0.7	1.0	1.0	1.0	38.6	4.1	1.3	0.9	0.6	0.6	0.2	2.4	41.6	1.0	3.0	0.2	0.0	37.7	1.1	1.0	122.0	1.7	0.3	0.8	6.9	7.5	0.7	1.0	7.6	109.6	1.2	20.5	2.1	132.2	1.2	28.8	0.0	0.0	0.0	0.5	1.4	350.3	2.7	1.5	1.0	0.4	3.7	14.0	0.1	22.5	24.3	0.1	12.5	0.0	1.2	0.0	0.0	0.2	0.0	20.7	4.5	3.9	0.0	0.0	1.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	168.1	0.1	0.2	0.1	58.4	5.8	0.0	0.5	0.0	0.0	0.0	0.8	0.0	45.9	65.0	0.0	0.0	147.2	0.0	118.4	0.0	4.1	2.5	0.1	0.0	0.0	0.1	0.5	0.0	0.0	2.9	0.8	2.6	232.3	2.1	99.3	2.6	32.0	143.8	9.4	5.5	6.9	120.4	10.3	283.2	2.3	2635.7	11.5	168.3	0.9	1.0	1.3	1.6	0.7	1.0	1.3	0.9	1.0	0.8	1.0	1.2	11.5	214.7	42.0	0.0	11.6	3.8	3.6	86.6	8.0	0.0	7.3	20.6	3.2	2.8	95.2	1.8	0.0	811.8	456.0	25.2	9.8	1.8	1.7	16.7	2.3	13.4	4.9	5.3	0.0	6.4	1219.2	27.0	22.4	14.4	1.3	1.8	3.6	1.1	91.6	0.0	0.0	5.6	4.1	2.2	5.9	7.8	125.6	8.5	10.6	1.9	4.9	0.0	541.7	0.0	0.0	84.6	10.4	41.8	23.7	4.5	0.7	0.4	12.0	0.0	0.0	0.2	4.4	0.0	1.0	70.2	19.5	2039.4	78.4	1.0	5.2	18.1
CNOT7	CAF1	ENSG00000198791	"CCR4-NOT transcription complex subunit 7"	Q9UIV1	8	17224966-17246878	"Enzymes, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Exonuclease, Hydrolase, Nuclease, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069543			Supported	"Nuclear bodies"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nuclear bodies"		"HPA069543: AB_2686148"	"unprognostic (1.55e-1)"	"unprognostic (4.49e-2)"	"prognostic favorable (4.99e-4)"	"unprognostic (4.61e-2)"	"unprognostic (8.45e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.44e-3)"	"unprognostic (4.54e-2)"	"unprognostic (6.83e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.51e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.52e-1)"	31.9	32.7	21.6	39.8	25.4	51.0	42.1	35.0	30.7	28.0	20.5	43.0	38.3	39.5	45.1	43.7	36.3	35.7	38.2	24.2	26.8	50.8	48.8	33.0	52.2	19.7	23.3	42.1	36.0	62.6	26.2	43.1	20.3	32.7	43.8	78.0	38.5	29.5	78.9	27.8	38.4	36.6	21.5	39.0	32.0	52.0	24.4	80.2	60.0	72.2	64.9	45.0	20.4	24.0	77.3	93.6	138.1	103.1	57.0	59.6	95.3	97.6	82.5	110.4	97.5	110.2	60.4	106.1	103.9	85.9	177.5	60.3	147.0	122.9	160.2	44.1	71.0	139.9	68.6	119.9	73.2	95.3	82.8	57.3	99.7	94.3	100.3	102.0	133.7	138.2	119.1	114.9	112.9	60.2	234.7	88.2	152.6	144.4	72.0	126.1	102.7	79.9	95.6	167.6	173.6	115.9	68.6	60.3	114.4	112.9	72.5	79.2	90.8	82.0	116.5	92.4	110.8	59.3	208.2	189.5	76.9	88.7	82.8	138.0	93.9	109.5	80.2	116.6	95.3	133.3	109.7	95.7	113.5	135.3	136.6	110.0	84.5	106.5	105.1	101.3	134.8	130.1	21.6	25.4	35.0	30.7	24.2	26.8	19.7	23.3	20.3	21.5	24.4	24.0	46.9	32.1	40.3	15.0	100.4	90.9	65.2	82.5	100.7	114.9	77.1	64.0	58.2	61.5	48.2	62.5	93.8	88.4	74.5	31.0	97.8	79.0	86.5	50.7	37.1	56.8	94.1	60.5	39.1	72.5	115.1	45.9	40.2	53.5	44.9	72.2	69.3	67.2	69.7	25.2	32.1	69.6	81.4	73.5	58.7	33.9	40.7	59.4	26.6	28.1	83.7	68.5	76.2	23.1	34.8	79.3	58.1	40.6	84.0	93.8	52.6	113.9	56.6	219.2	78.9	51.6	56.2	95.9	100.7	90.7	86.0	85.5	77.6	55.3	70.5	84.3
DISP1	"DISPA, DKFZP434I0428, MGC13130, MGC16796"	ENSG00000154309	"Dispatched RND transporter family member 1"	Q96F81	1	222815022-223005995	"Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 47.7;Gastric mucus-secreting cells: 48.4;Inhibitory neurons: 54.4;Microglial cells: 204.2;Oligodendrocyte precursor cells: 199.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RH-30: 15.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051411	Uncertain		Approved	"Nuclear bodies"		No	No			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nuclear bodies"		"HPA051411: AB_2681475"	"unprognostic (2.10e-2)"	"unprognostic (3.31e-1)"	"unprognostic (7.00e-2)"	"unprognostic (7.81e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.28e-1)"	"prognostic favorable (5.00e-4)"	"unprognostic (4.13e-1)"	"prognostic favorable (3.86e-5)"	"unprognostic (5.24e-2)"	"unprognostic (2.38e-1)"	"prognostic favorable (4.16e-4)"	"unprognostic (9.69e-3)"	6.8	5.7	1.7	1.5	2.0	0.2	3.0	4.0	2.5	3.2	3.7	9.0	2.6	4.3	2.0	1.9	2.4	4.6	3.9	1.6	1.9	5.2	2.7	9.2	1.1	1.2	0.9	4.5	2.4	5.1	2.5	4.6	1.1	2.4	2.1	1.3	1.9	2.0	4.1	3.3	3.7	4.2	0.7	2.5	5.3	6.5	1.5	1.4	5.2	3.1	1.4	5.4	2.5	2.6	0.9	2.2	5.6	3.8	10.1	6.1	2.4	3.2	2.7	1.1	1.1	2.6	1.6	0.1	4.2	1.5	2.2	0.6	1.6	1.3	1.6	8.1	2.4	1.1	6.3	1.2	4.4	0.2	1.1	4.8	1.9	2.3	0.9	5.8	2.3	1.2	0.0	0.1	3.9	1.5	1.4	0.3	4.0	6.1	1.3	1.7	15.1	0.2	6.8	0.8	1.6	2.5	1.8	0.7	2.3	2.7	2.7	1.4	4.2	2.3	1.5	3.9	3.6	1.2	0.5	0.3	3.2	0.8	5.1	0.3	0.2	0.0	0.7	0.4	1.6	0.5	0.6	0.7	0.6	0.9	0.6	0.5	0.1	1.0	0.2	0.3	0.5	0.4	1.7	2.0	4.0	2.5	1.6	1.9	1.2	0.9	1.1	0.7	1.5	2.6	4.6	6.4	1.7	42.7	3.6	0.5	0.6	1.2	5.7	2.7	3.4	1.5	7.8	7.2	3.3	11.0	0.0	1.4	2.1	1.0	0.0	1.9	2.1	1.9	3.4	4.9	0.0	0.0	47.7	2.8	1.8	5.6	48.4	4.1	0.0	15.8	6.8	3.3	5.9	0.0	54.4	2.6	4.1	1.6	0.9	3.7	1.5	4.1	0.0	204.2	1.4	0.9	5.2	199.6	15.4	1.3	3.1	3.4	0.7	0.7	6.4	5.8	2.7	2.3	0.0	4.0	3.7	2.1	2.3	5.4	1.1	0.8	1.7	2.8	1.6	0.3
DLX6		ENSG00000006377	"Distal-less homeobox 6"	P56179	7	97005553-97011040	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 7.3;testis: 5.5"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 32.9;Early spermatids: 22.6;Endometrial ciliated cells: 37.3;Extravillous trophoblasts: 70.4;Glandular and luminal cells: 27.5;Syncytiotrophoblasts: 17.4"	"Cancer enriched"	"Detected in many"	8	"endometrial cancer: 12.5"	"Region enhanced"	"Detected in many"		"basal ganglia: 7.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 10.1;BEWO: 33.4;HAP1: 15.3;SH-SY5Y: 11.0;SuSa: 19.3"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"olfactory bulb: 27.0"	"HPA030608, HPA061460"	Uncertain		Approved	"Nuclear bodies"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nuclear bodies"		"HPA030608: AB_10600867, HPA061460: AB_2684529"	"unprognostic (7.50e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.19e-2)"	"unprognostic (8.06e-2)"	"unprognostic (8.16e-2)"	"unprognostic (3.05e-1)"		"unprognostic (4.32e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.86e-1)"	"unprognostic (6.56e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.12e-7)"	"unprognostic (5.60e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.58e-2)"	"unprognostic (8.12e-2)"	0.4	0.0	2.1	0.0	7.3	0.3	0.1	0.0	4.3	2.0	0.0	0.2	0.0	2.5	0.8	0.0	0.4	0.0	0.1	0.8	4.7	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.1	3.0	0.0	0.3	0.0	0.0	1.1	0.9	0.1	1.5	0.0	0.2	0.0	0.1	0.0	5.5	1.2	0.3	0.4	0.1	0.2	0.3	0.2	0.4	0.0	0.0	0.0	10.1	0.0	0.0	33.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	6.1	0.0	0.0	1.9	15.3	0.0	0.0	0.0	3.9	0.0	5.9	7.1	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	2.6	1.6	0.0	0.0	0.0	0.0	2.2	7.3	11.0	1.0	0.0	0.3	19.3	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.1	0.0	0.9	1.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	7.3	0.0	4.3	0.8	4.7	0.0	0.0	0.0	0.0	1.2	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	32.9	0.1	0.0	0.0	0.0	22.6	37.3	2.2	0.2	0.0	0.0	0.0	0.0	70.4	0.2	0.0	27.5	0.0	0.0	0.0	0.0	3.3	0.0	8.0	0.0	0.0	0.0	0.0	3.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.8	6.8	10.2	0.0	0.0	17.4	0.3	0.0	0.0	0.1
DPH7	"C9orf112, FLJ90634, RRT2, WDR85"	ENSG00000148399	"Diphthamide biosynthesis 7"	Q9BTV6	9	137554444-137578925	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 189.9;Spermatogonia: 100.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022911	Uncertain		Approved	"Nuclear bodies"		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 50: Non-specific - Ribosome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear bodies"		"HPA022911: AB_1858823"	"unprognostic (1.43e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.60e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.14e-2)"	"unprognostic (9.48e-2)"	"prognostic favorable (6.52e-4)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (1.52e-5)"	"unprognostic (2.30e-3)"	"unprognostic (3.06e-2)"	"unprognostic (2.15e-1)"	"prognostic favorable (3.23e-4)"	8.2	12.3	3.4	2.6	3.6	4.2	9.5	4.5	4.1	15.7	3.9	13.8	2.2	12.6	7.0	9.0	14.6	2.6	9.4	3.6	3.3	10.2	10.9	9.4	4.7	3.7	3.3	12.8	20.3	6.3	13.5	3.4	4.0	15.0	4.1	2.8	9.9	5.4	8.3	11.0	12.2	4.8	3.3	15.2	12.3	9.3	3.8	5.6	12.8	2.4	5.3	11.2	11.1	5.7	4.5	5.2	8.2	7.6	6.2	5.1	10.2	5.1	5.2	9.1	7.7	11.0	5.4	10.6	9.3	5.9	4.8	9.8	10.6	10.1	8.3	9.2	13.2	4.9	6.6	3.7	7.0	10.6	9.5	5.4	7.6	5.1	9.2	6.5	14.4	7.1	9.2	5.7	7.2	15.3	8.2	9.9	10.4	19.9	13.3	13.7	3.7	7.6	6.9	4.5	10.8	7.3	8.7	7.0	5.4	5.7	7.9	9.1	6.5	6.2	5.4	7.7	9.5	3.7	9.1	12.5	3.9	6.1	6.3	9.5	5.1	6.2	4.5	4.8	6.3	5.6	7.2	6.4	5.9	4.7	5.1	4.9	1.6	4.5	4.0	8.0	5.4	4.6	3.4	3.6	4.5	4.1	3.6	3.3	3.7	3.3	4.0	3.3	3.8	5.7	21.0	6.4	11.9	21.2	17.7	16.7	9.8	18.9	8.0	18.7	14.7	20.6	15.5	2.8	11.5	1.8	50.1	22.1	22.5	7.7	3.9	10.6	3.0	11.1	17.1	13.8	6.7	5.5	17.2	9.2	14.9	14.5	13.3	10.2	10.8	26.5	8.2	6.5	11.9	16.8	21.5	11.7	6.1	6.6	7.2	7.5	16.4	8.8	8.8	15.0	9.9	15.4	23.7	16.1	28.2	11.5	10.3	15.8	24.7	18.6	7.2	5.2	14.2	58.8	19.7	13.1	16.0	189.9	100.0	11.4	18.9	12.2	18.0	19.9	15.0	11.1
DTWD2	FLJ33977	ENSG00000169570	"DTW domain containing 2"	Q8NBA8	5	118836074-118988547	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 70.4;Inhibitory neurons: 61.8;Oligodendrocyte precursor cells: 49.3;Oligodendrocytes: 43.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA053173, HPA054864"	Approved		Approved	"Nuclear bodies"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear bodies"		"HPA053173: AB_2682068, HPA054864: AB_2682629"	"unprognostic (1.66e-1)"	"unprognostic (1.60e-1)"	"prognostic favorable (3.16e-4)"	"unprognostic (4.80e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.77e-3)"	"unprognostic (5.15e-2)"	"unprognostic (2.90e-1)"	"prognostic favorable (6.09e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.59e-1)"	3.1	3.3	1.3	2.3	1.3	1.2	3.6	2.3	1.8	5.1	2.2	3.3	3.2	2.6	2.3	4.2	2.3	3.2	6.5	1.2	0.8	6.5	4.5	2.4	2.3	1.1	1.4	1.7	3.0	4.7	0.8	1.8	1.2	3.4	3.3	3.4	3.2	2.7	10.5	3.3	2.7	3.2	1.0	3.0	2.7	2.4	1.3	2.0	9.1	6.3	2.3	2.9	1.3	1.4	4.3	2.6	3.6	5.3	2.0	1.0	3.6	3.9	2.7	5.5	6.3	1.8	3.2	3.6	6.9	3.4	2.6	4.8	6.0	4.4	6.9	1.2	4.2	4.9	4.3	2.9	1.7	5.9	6.1	1.5	7.4	2.4	2.4	3.2	1.8	6.4	3.8	5.5	3.7	4.2	4.9	3.6	3.8	3.1	1.4	2.0	3.3	1.9	7.0	6.2	1.8	3.3	3.9	4.2	5.4	2.9	9.7	3.9	2.2	6.9	5.1	2.3	5.7	3.8	6.6	2.8	4.0	3.5	3.4	0.9	0.3	0.1	0.2	0.3	0.3	0.4	0.3	0.3	0.3	0.6	0.4	0.4	0.6	0.5	0.3	0.5	0.1	0.4	1.3	1.3	2.3	1.8	1.2	0.8	1.1	1.4	1.2	1.0	1.3	1.4	2.7	9.6	3.6	33.6	5.7	2.8	2.7	3.9	8.6	12.0	5.4	2.8	11.7	8.6	4.7	7.3	16.7	2.7	3.7	4.0	9.8	2.9	12.8	4.2	1.9	2.0	4.2	12.6	70.4	8.3	1.1	3.0	9.7	3.6	0.0	4.5	1.8	5.6	3.9	20.2	61.8	2.0	4.1	2.6	2.5	20.3	2.5	4.5	7.2	21.5	4.6	7.3	4.1	49.3	43.9	1.9	5.2	2.2	8.0	2.1	3.7	12.1	3.1	9.1	0.0	4.5	2.8	12.7	17.4	10.0	3.7	0.7	2.8	7.3	3.4	3.4
EVI5L		ENSG00000142459	"Ecotropic viral integration site 5 like"	Q96CN4	19	7830233-7864976	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 30.5;Horizontal cells: 33.7;Late spermatids: 32.6;Oligodendrocyte precursor cells: 50.3;Oligodendrocytes: 69.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"U-2197: 53.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043099, HPA043563"	Approved		Approved	"Nuclear bodies"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"	"Nuclear bodies"		"HPA043099: AB_10796685, HPA043563: AB_2678556"	"unprognostic (3.90e-2)"	"unprognostic (4.69e-2)"	"unprognostic (9.29e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.90e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.00e-1)"	"unprognostic (7.48e-3)"	"unprognostic (1.97e-2)"	"prognostic favorable (2.18e-6)"	"unprognostic (1.07e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.04e-2)"	6.8	10.4	29.5	5.0	30.2	3.1	6.6	23.0	35.2	9.4	2.5	13.4	4.9	11.2	4.6	10.6	8.4	5.1	17.1	30.5	27.6	11.6	6.3	7.2	4.2	34.1	28.5	7.3	6.3	8.8	16.4	7.9	29.8	12.1	4.1	11.1	7.5	9.1	20.5	13.7	6.9	8.7	21.3	8.1	9.3	36.1	32.1	6.4	8.6	14.9	4.4	11.1	9.0	41.1	13.5	2.7	10.5	15.4	18.8	15.7	29.5	19.7	20.5	13.8	14.7	1.1	5.0	3.4	23.1	26.9	7.3	9.1	3.8	13.4	12.7	19.6	12.7	2.6	6.3	2.2	23.7	3.1	6.7	14.7	15.9	6.8	31.9	11.4	16.9	17.5	3.1	17.8	14.4	13.8	10.8	6.8	3.9	10.0	28.4	13.0	8.7	10.0	8.3	11.3	4.3	10.3	18.3	8.1	5.8	7.0	6.8	9.9	16.7	9.4	4.4	53.6	7.4	25.7	6.2	4.6	15.9	7.5	8.3	0.0	0.1	0.0	0.2	0.2	0.2	0.0	0.1	0.1	0.0	0.0	0.2	0.3	0.1	0.1	1.1	0.1	0.2	0.0	29.5	30.2	23.0	35.2	30.5	27.6	34.1	28.5	29.8	21.3	32.1	41.1	3.6	0.0	5.1	13.1	1.6	3.8	2.2	2.4	2.2	30.5	3.6	3.3	4.0	2.8	1.8	9.2	18.8	3.7	1.6	7.4	0.0	2.4	14.8	2.2	4.3	3.8	5.4	1.3	16.3	2.6	16.9	3.1	6.1	4.2	0.0	5.7	3.6	2.0	3.8	33.7	19.7	4.2	6.1	2.5	1.1	32.6	4.1	2.8	3.6	9.4	1.1	7.1	1.0	50.3	69.8	3.0	3.5	4.5	2.0	2.5	1.7	4.1	1.8	18.8	6.6	2.0	4.0	18.3	7.3	3.6	4.1	3.4	2.2	8.2	3.4	5.1
FBXL3	"FBL3, FBL3A, FBXL3A"	ENSG00000005812	"F-box and leucine rich repeat protein 3"	Q9UKT7	13	76992598-77027195	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Biological rhythms, Ubl conjugation pathway"		"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053283, HPA065626"			Enhanced	"Nuclear bodies"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nuclear bodies"		"HPA053283: AB_2682100, HPA065626: AB_2685523"	"unprognostic (3.98e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.24e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.12e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.10e-3)"	"unprognostic (8.52e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.78e-1)"	45.7	25.0	17.9	24.0	20.4	69.1	42.6	23.5	26.1	31.7	12.4	27.4	24.0	31.4	23.1	27.9	27.4	24.2	25.1	17.1	17.5	37.8	31.4	29.8	32.7	17.6	17.4	44.6	20.8	29.7	9.7	32.5	18.3	29.9	25.1	21.1	22.9	26.2	30.0	30.5	25.0	27.8	18.5	31.3	22.2	30.0	17.0	36.2	48.0	37.9	31.4	25.4	23.1	28.1	43.4	11.1	21.4	14.8	50.7	50.1	17.0	48.6	39.6	28.3	36.0	16.0	30.1	27.9	31.6	43.1	17.1	31.9	21.4	26.1	40.4	55.7	56.8	36.2	32.9	14.3	33.6	46.7	26.9	42.5	34.2	22.6	31.0	33.1	37.7	15.3	14.0	20.8	34.0	15.8	33.7	25.0	8.2	37.0	20.1	27.3	24.3	17.0	30.2	22.7	25.2	20.5	31.0	30.0	28.4	14.5	16.6	51.1	46.7	27.1	17.8	18.6	23.9	26.5	32.9	25.6	46.9	33.1	30.0	8.0	1.9	4.6	2.1	2.9	2.9	2.6	3.8	2.2	1.9	2.8	4.5	3.1	5.2	2.1	3.1	2.0	5.1	1.4	17.9	20.4	23.5	26.1	17.1	17.5	17.6	17.4	18.3	18.5	17.0	28.1	35.9	44.8	22.2	31.6	48.9	67.3	38.0	17.0	50.1	25.1	36.5	21.6	21.6	12.8	15.4	22.0	10.4	33.0	42.4	54.8	41.1	17.9	41.2	26.8	29.0	38.3	23.9	50.7	30.4	18.8	41.7	42.8	17.3	34.7	28.5	20.4	32.2	28.5	23.3	37.0	29.8	23.9	22.4	36.1	41.5	24.6	74.6	33.3	42.7	37.5	36.5	45.4	20.6	33.7	58.1	19.1	25.7	74.9	33.6	40.2	38.3	29.2	19.9	24.3	59.2	46.1	52.7	52.5	58.9	40.9	56.1	28.5	44.9	22.7	23.1	38.5
FBXO48		ENSG00000204923	"F-box protein 48"	Q5FWF7	2	68459422-68467294	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 32.1;Alveolar cells type 2: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA049775, HPA054782"	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Nuclear bodies"		"HPA049775: AB_2680874, HPA054782: AB_2682599"	"unprognostic (2.90e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.75e-3)"	"unprognostic (6.56e-3)"	"unprognostic (2.90e-3)"	"unprognostic (2.30e-1)"	"unprognostic (4.74e-2)"	"unprognostic (6.01e-3)"	"unprognostic (3.92e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.09e-2)"	"unprognostic (6.42e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.39e-3)"	"unprognostic (1.89e-2)"	1.1	1.2	1.3	1.4	1.8	0.7	1.3	1.5	1.5	1.1	1.2	1.1	1.8	0.8	1.1	1.1	0.7	0.8	0.7	1.3	1.2	1.4	2.0	1.0	1.7	1.5	1.4	1.7	0.8	1.3	0.5	1.2	1.7	0.8	1.2	3.0	1.3	0.7	3.1	2.5	1.5	0.6	1.2	1.8	1.3	1.0	1.7	1.2	1.1	1.8	1.8	0.7	0.9	2.7	2.1	0.7	1.3	0.9	1.6	1.8	0.9	1.5	1.8	1.4	1.6	1.0	0.9	2.6	1.0	0.7	1.9	1.1	1.2	1.2	2.7	3.5	1.3	1.3	0.7	0.5	0.7	0.6	1.5	0.8	2.1	2.0	1.7	0.7	0.6	4.3	0.6	4.9	1.1	0.4	1.5	1.9	0.7	1.4	1.0	1.3	2.3	1.7	1.1	0.6	1.3	0.9	0.7	0.3	1.7	1.1	0.4	0.6	0.6	1.6	1.5	2.0	1.6	3.9	2.5	1.1	1.0	1.1	1.2	2.6	0.7	0.9	1.0	0.7	1.0	0.9	1.7	1.0	0.4	1.0	1.2	1.2	1.4	1.0	1.3	0.9	2.1	0.6	1.3	1.8	1.5	1.5	1.3	1.2	1.5	1.4	1.7	1.2	1.7	2.7	9.1	32.1	52.0	1.3	6.4	7.1	5.0	3.1	9.1	3.9	7.7	10.4	11.7	7.2	16.3	5.5	2.1	4.2	4.5	7.1	11.7	3.2	1.7	4.0	3.1	8.2	3.0	4.0	0.8	3.3	3.5	6.8	3.1	4.1	12.6	2.1	5.3	7.1	4.1	3.3	0.8	6.2	0.0	5.1	6.6	1.0	4.1	8.7	1.8	0.0	2.5	2.2	2.1	1.5	1.7	3.1	2.7	1.5	5.8	3.4	7.4	9.2	12.9	5.7	0.0	5.5	3.9	18.0	11.1	6.7	8.0	1.6	8.1	2.8	3.5	3.9
GATA4		ENSG00000136574	"GATA binding protein 4"	P43694	8	11676959-11760002	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Atrial septal defect, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 88.6;ovary: 95.4;pancreas: 53.5"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 41.4;Exocrine glandular cells: 33.7;Gastric mucus-secreting cells: 61.2;Granulosa cells: 158.4;Hepatic stellate cells: 57.8;Late spermatids: 37.0;Leydig cells: 41.3;Peritubular cells: 41.3;Theca cells: 80.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 21.8;testis cancer: 12.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 19.7;HHSteC: 20.9;OE19: 6.2;SH-SY5Y: 20.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB013125, HPA073899"	Uncertain		Supported	"Nuclear bodies"		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear bodies"		"CAB013125: AB_2533804, HPA073899: AB_2686641"	"unprognostic (2.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.36e-1)"	"unprognostic (8.68e-4)"	"unprognostic (2.66e-3)"	"unprognostic (1.71e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.02e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.67e-8)"	"unprognostic (1.09e-1)"	"unprognostic (1.61e-1)"		"unprognostic (1.29e-2)"	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	20.2	0.2	0.0	0.0	2.3	4.0	88.6	0.0	0.0	0.0	36.6	0.2	0.0	0.0	0.0	95.4	53.5	0.0	0.1	7.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.1	35.2	32.4	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	1.2	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	19.7	20.9	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.2	0.0	0.0	0.2	1.3	0.0	0.0	1.5	20.5	0.0	0.0	0.1	3.9	1.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.4	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	16.1	0.0	0.1	6.1	0.0	0.0	0.1	33.7	0.2	12.0	61.2	0.0	0.0	158.4	57.8	12.1	0.6	0.0	0.1	0.8	0.0	2.8	0.0	37.0	41.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.5	0.0	41.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	5.3	2.4	2.2	0.0	0.0	0.8	0.1	80.1	0.9	0.0
HDC		ENSG00000140287	"Histidine decarboxylase"	P19113	15	50241947-50265965	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 102.9;epididymis: 46.1"	"Cell type enriched"	"Detected in some"	12	"granulocytes: 596.0"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.9;testis cancer: 2.7"	"Region enriched"	"Detected in many"	6	"hypothalamus: 102.9"	"Immune cell enriched"	"Detected in single"	2140	"basophil: 686.2"	"Lineage enriched"	"Detected in single"	2140	"granulocytes: 686.2"	"Group enriched"	"Detected in some"	4	"HEL: 460.8;HMC-1: 1051.3"	"Region enriched"	"Detected in many"	5	"hypothalamus: 43.9"	"Group enriched"	"Detected in some"	10	"hypothalamus: 16.5;midbrain: 4.2"	HPA038891	Enhanced		Approved	"Nuclear bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Nuclear bodies"		"HPA038891: AB_10673231"	"unprognostic (4.97e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.43e-4)"	"unprognostic (1.08e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.93e-7)"	"unprognostic (4.18e-5)"	"unprognostic (8.79e-3)"	"unprognostic (1.48e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.53e-1)"	"unprognostic (7.20e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.50e-1)"	2.3	0.4	0.0	3.5	5.6	4.7	1.4	0.0	0.2	2.3	0.7	3.8	4.1	2.5	46.1	4.8	0.8	11.2	0.7	0.2	102.9	0.4	0.5	6.9	0.9	0.0	13.7	0.1	1.2	0.5	0.4	0.4	0.0	1.7	3.6	0.8	1.3	0.9	0.3	2.3	4.6	2.5	0.0	0.5	12.9	1.3	17.8	0.9	0.1	0.8	1.0	3.8	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	460.8	0.2	0.0	0.0	1.2	1051.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.5	181.8	0.3	0.0	0.0	0.2	0.4	0.4	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.5	0.2	0.4	686.2	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	1.6	0.0	5.6	0.0	0.2	0.2	102.9	0.0	13.7	0.0	0.0	17.8	0.1	0.0	12.8	47.5	0.3	0.0	0.8	0.0	0.0	0.0	2.6	0.0	0.0	0.5	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	10.9	0.3	0.0	0.0	2.3	9.2	0.0	596.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	1.8	0.4	0.0	1.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	3.8	0.0	0.0	0.0	4.5	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	3.5	0.0	0.1	0.1
HOXA4	"HOX1, HOX1D"	ENSG00000197576	"Homeobox A4"	Q00056	7	27128507-27130780	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 11.6;Basal squamous epithelial cells: 31.9;Distal tubular cells: 15.6;Hepatic stellate cells: 16.8;Proximal tubular cells: 13.1;Squamous epithelial cells: 12.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"medulla oblongata: 19.3;pons: 16.1;spinal cord: 15.6;white matter: 14.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 29.0;HEK 293: 22.2;REH: 21.0;WM-115: 29.1"	"Region enriched"	"Detected in single"	46	"pons and medulla: 11.3"					HPA060088	Approved		Supported	"Nuclear bodies"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear bodies"		"HPA060088: AB_2684200"	"unprognostic (3.37e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (6.37e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.23e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.59e-4)"	"unprognostic (3.93e-2)"	16.2	10.0	0.0	2.1	0.0	0.7	10.5	0.1	0.1	5.5	0.0	13.2	4.9	5.9	13.0	15.3	22.1	3.6	1.9	0.0	0.0	16.3	1.5	14.7	1.3	19.3	1.6	6.8	1.9	25.8	0.0	0.1	16.1	5.9	2.4	0.0	0.6	5.8	18.8	4.9	8.2	4.6	15.6	6.9	13.4	1.6	0.0	1.9	3.7	8.2	0.4	7.7	4.6	14.1	9.5	3.1	0.0	29.0	0.0	0.0	1.9	0.9	0.9	3.0	3.0	5.9	1.9	2.5	0.1	2.8	2.7	4.0	1.1	0.4	2.3	0.1	22.2	0.0	0.9	13.7	3.3	3.3	5.4	3.2	2.4	10.2	0.8	0.0	10.3	0.8	0.0	0.0	10.0	2.5	0.0	11.2	0.0	3.3	7.2	21.0	4.4	0.2	14.6	2.2	1.4	0.0	2.9	0.0	11.2	1.0	0.7	1.7	13.5	0.0	4.6	7.6	0.2	0.0	0.0	1.0	6.1	5.1	29.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	19.3	1.6	16.1	15.6	0.0	14.1	11.6	0.0	0.0	0.0	0.1	0.9	3.1	0.0	31.9	0.0	3.6	7.7	0.4	0.0	0.0	0.0	0.0	0.0	0.4	1.7	15.6	0.0	0.4	0.2	2.6	5.2	3.0	0.8	0.0	0.0	0.9	5.4	0.5	0.1	0.0	0.4	16.8	0.0	0.2	0.0	0.0	0.9	0.0	0.6	0.3	0.4	0.0	0.9	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.5	0.7	1.4	0.7	1.0	13.1	0.0	0.0	0.0	8.3	5.8	0.4	3.2	12.5	1.3	0.1	0.8	1.4	2.0	2.5
INTS7	"C1orf73, DKFZP434B168, INT7"	ENSG00000143493	"Integrator complex subunit 7"	Q9NVH2	1	211940399-212035557	"Predicted intracellular proteins"	"DNA damage"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 35.6;Oligodendrocytes: 46.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072611			Supported	"Nuclear bodies"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear bodies"		"HPA072611: AB_2732204"	"unprognostic (1.25e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.63e-2)"	"unprognostic (4.26e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.66e-3)"	"unprognostic (2.80e-3)"	"unprognostic (1.37e-2)"	"unprognostic (9.80e-2)"	"unprognostic (4.46e-1)"	"prognostic unfavorable (1.42e-5)"	"unprognostic (2.48e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.11e-1)"	"unprognostic (7.44e-2)"	5.5	5.1	5.4	6.3	7.1	7.9	6.7	5.8	8.5	5.1	5.3	6.3	5.8	4.6	6.6	8.2	4.5	4.5	4.7	5.3	5.7	4.4	11.1	5.1	9.1	6.0	6.1	4.3	4.7	2.7	5.6	5.8	6.8	5.5	7.6	7.8	4.2	3.1	5.4	7.6	5.4	7.1	5.5	6.0	5.3	21.4	5.7	13.6	6.6	8.5	10.2	6.4	5.5	9.0	31.1	27.2	21.4	17.1	15.3	16.7	25.7	24.9	15.8	29.2	36.8	25.8	26.4	36.0	13.1	18.1	22.7	27.9	32.2	20.0	24.2	34.8	27.5	31.3	27.9	19.0	16.6	56.3	27.9	14.9	24.1	46.8	35.4	13.8	17.7	19.5	46.8	31.2	24.3	18.1	45.6	16.1	39.2	21.3	26.8	27.9	39.7	53.0	16.9	23.2	36.1	28.2	32.4	34.7	20.6	24.7	28.9	26.7	12.6	23.7	25.5	22.0	37.5	13.5	24.3	42.8	21.0	22.8	27.2	12.6	7.3	6.1	8.7	7.5	7.3	9.4	8.7	10.4	10.9	10.9	5.2	6.4	0.8	22.2	10.0	7.6	15.0	7.6	5.4	7.1	5.8	8.5	5.3	5.7	6.0	6.1	6.8	5.5	5.7	9.0	2.4	0.0	12.0	9.1	7.3	9.9	8.2	4.6	10.8	8.5	5.9	3.7	4.9	5.7	4.6	3.7	4.2	10.5	6.9	6.7	1.9	5.1	35.0	5.1	4.9	4.6	1.2	11.6	20.4	7.0	7.9	5.7	6.6	4.5	4.5	8.1	4.6	10.8	5.5	5.0	24.5	5.6	6.1	4.7	5.1	35.6	5.0	3.8	1.8	19.7	6.2	4.2	10.3	34.7	46.6	5.5	1.9	6.8	9.1	4.2	4.4	3.3	6.2	5.6	0.0	5.4	4.5	31.5	18.8	9.9	11.9	6.8	6.7	17.7	8.3	3.9
LACTBL1		ENSG00000215906	"Lactamase beta like 1"	A8MY62	1	22953043-22965338	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"retina: 3.0"	"Cell type enriched"	"Detected in single"	10	"Bipolar cells: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA066810			Approved	"Nuclear bodies"		NA	NA				"Cluster 77: Retina - Visual perception"		"Cluster 56: Bipolar cells - Visual perception"	"Nuclear bodies"		"HPA066810: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LYRM4	"C6orf149, CGI-203, ISD11"	ENSG00000214113	"LYR motif containing 4"	Q9HD34	6	5103629-5260950	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA030362	Approved		Supported	"Nuclear bodies"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	"Nuclear bodies"		"HPA030362: AB_10601546"	"unprognostic (2.41e-2)"	"unprognostic (3.72e-2)"	"unprognostic (7.68e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.30e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.85e-3)"	"unprognostic (4.58e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.79e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.76e-1)"	"unprognostic (9.80e-2)"	"unprognostic (5.23e-1)"	16.9	18.8	22.8	14.6	22.5	19.0	19.0	21.4	31.0	16.2	24.0	14.7	7.7	18.1	18.1	13.4	19.1	11.2	20.5	22.3	22.1	14.5	13.6	12.1	22.9	22.7	21.7	27.1	19.4	15.9	20.4	14.2	22.3	12.3	16.2	15.9	13.0	10.2	14.4	17.1	10.4	16.6	22.3	15.9	14.1	16.0	21.8	20.8	19.5	11.0	21.8	16.9	14.2	24.1	28.9	27.4	41.1	32.0	41.3	60.1	37.1	27.1	44.0	36.9	38.0	57.8	19.2	44.7	51.7	35.8	51.6	25.4	58.9	34.2	41.0	79.4	45.9	19.7	20.9	77.4	25.9	52.2	19.2	47.9	53.1	33.1	43.3	34.9	35.8	42.4	64.3	15.2	32.1	15.6	49.6	70.5	39.6	45.9	42.1	49.2	30.8	82.2	38.6	23.4	55.2	35.6	23.8	14.6	65.5	58.6	39.8	44.7	29.5	39.2	26.3	32.9	44.8	22.4	82.4	42.7	19.0	36.6	54.2	1.9	18.8	2.1	11.7	19.8	15.6	31.3	17.5	13.3	34.4	26.2	26.6	24.6	4.3	23.6	17.5	23.0	19.1	17.6	22.8	22.5	21.4	31.0	22.3	22.1	22.7	21.7	22.3	22.3	21.8	24.1	75.6	25.6	16.2	28.4	45.0	73.5	55.6	80.9	25.0	16.4	51.9	48.4	29.1	28.6	33.9	18.4	8.4	49.5	23.0	12.3	31.3	44.1	38.8	26.0	29.3	40.3	32.3	32.0	103.4	43.8	72.2	37.6	11.2	19.0	41.3	39.6	41.7	35.9	65.2	11.8	57.4	26.5	32.6	46.8	93.0	91.7	46.3	31.7	69.4	32.8	74.2	45.1	23.7	80.4	50.8	34.1	15.3	35.3	32.6	108.9	7.2	90.0	26.6	16.8	32.9	32.2	34.8	79.4	78.7	32.1	82.8	47.2	29.5	43.9	38.6	63.5
MCIDAS	"IDAS, MCI, MCIN"	ENSG00000234602	"Multiciliate differentiation and DNA synthesis associated cell cycle protein"	D6RGH6	5	55219564-55227315	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cilium biogenesis/degradation, Transcription, Transcription regulation"	Activator	"Ciliopathy, Disease variant, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"parathyroid gland: 2.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Collecting duct cells: 1.8;Endometrial ciliated cells: 1.2;Respiratory ciliated cells: 3.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 4.9;HeLa: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049981, HPA058073"	Uncertain		Supported	"Nuclear bodies"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 20: HeLa - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear bodies"		"HPA049981: , HPA058073: AB_2683596"	"unprognostic (3.11e-2)"	"unprognostic (7.50e-4)"	"unprognostic (2.48e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.67e-1)"	"unprognostic (2.90e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.70e-2)"	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	2.9	0.4	0.0	0.6	0.0	0.0	4.9	0.0	0.0	0.4	0.7	4.0	4.4	0.0	0.4	0.0	1.2	0.7	2.9	0.2	0.0	0.2	4.0	0.0	6.6	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	1.9	1.4	0.0	0.0	1.6	0.0	0.1	0.2	0.7	2.2	0.8	1.5	0.0	1.7	2.6	1.3	0.0	2.1	0.5	2.2	0.0	4.0	0.4	0.0	0.0	3.4	0.2	0.1	3.3	4.2	0.0	0.0	3.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.7	0.0	0.9	1.8	0.0	0.1	0.0	0.0	0.0	0.1	0.4	1.2	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.1	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1
MED19	LCMR1	ENSG00000156603	"Mediator complex subunit 19"	A0JLT2	11	57703714-57712323	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039912, HPA040860"	Uncertain		Enhanced	"Nuclear bodies"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 10: Non-specific - Unknown function"	"Nuclear bodies"		"HPA039912: AB_10795262, HPA040860: AB_10794153"	"unprognostic (2.61e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (1.34e-6)"	"unprognostic (1.40e-1)"	"unprognostic (4.87e-3)"	"prognostic favorable (1.76e-6)"	"unprognostic (3.08e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.14e-2)"	"unprognostic (6.71e-2)"	"unprognostic (6.97e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.38e-2)"	11.3	18.1	22.7	6.2	23.7	6.8	11.6	20.7	41.5	11.0	21.0	10.0	9.6	11.6	13.4	15.5	9.2	6.1	11.3	23.4	22.6	14.7	13.2	8.9	7.5	21.4	22.9	9.6	11.6	9.8	16.0	10.2	22.2	12.5	7.8	12.0	12.1	8.9	10.6	15.5	9.7	8.1	22.2	10.8	11.1	22.8	26.0	8.2	13.6	9.2	9.4	10.1	11.9	23.7	30.3	19.1	22.7	21.0	23.6	21.4	27.0	25.4	19.7	23.9	24.0	13.6	23.0	16.6	38.5	24.4	21.0	22.6	17.1	16.1	21.0	21.8	18.6	14.3	11.3	12.7	35.5	15.7	16.4	17.5	28.9	23.8	46.6	16.7	31.1	13.3	15.9	16.1	29.1	14.5	22.3	29.2	19.8	21.4	37.7	21.1	32.2	20.2	15.9	12.6	17.6	24.7	20.5	20.7	47.2	19.1	43.8	16.0	25.7	20.7	24.8	49.2	22.6	19.9	20.5	15.7	28.3	11.5	22.1	27.9	25.8	31.3	29.2	37.2	31.6	45.0	32.8	31.4	25.6	39.4	34.0	32.0	16.4	24.6	39.2	36.9	33.9	26.0	22.7	23.7	20.7	41.5	23.4	22.6	21.4	22.9	22.2	22.2	26.0	23.7	40.7	9.6	27.1	4.6	32.5	87.6	60.9	72.0	62.0	38.6	37.4	39.8	14.7	30.0	40.2	51.5	35.5	58.2	32.2	36.2	39.2	44.1	12.2	33.3	37.8	39.3	23.3	21.4	9.2	45.4	48.6	38.1	20.9	34.0	22.2	39.2	36.0	26.3	29.3	37.0	8.3	38.3	54.9	17.6	31.4	15.4	28.3	18.6	37.4	2.8	26.3	37.4	24.7	5.5	7.2	40.6	33.2	29.7	22.9	53.6	32.9	47.2	42.1	59.7	19.7	31.3	50.5	111.7	97.9	42.7	82.3	73.1	35.8	37.5	31.8	52.8
MED7	"CRSP33, CRSP9"	ENSG00000155868	"Mediator complex subunit 7"	O43513	5	157137424-157159019	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 314.5;Late spermatids: 289.0;Spermatocytes: 112.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067181			Supported	"Nuclear bodies"		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 6: T47d - Mammary gland"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear bodies"		"HPA067181: AB_2685798"	"unprognostic (1.63e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.81e-3)"	"unprognostic (8.12e-2)"	"unprognostic (1.45e-3)"	"unprognostic (6.05e-2)"	"prognostic unfavorable (2.37e-5)"	"unprognostic (7.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (8.69e-5)"	"unprognostic (9.68e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.39e-3)"	10.1	11.4	7.9	9.2	8.3	10.5	12.6	9.9	11.1	8.4	10.3	10.5	6.3	9.2	13.5	8.5	7.9	7.6	10.2	8.3	8.4	15.5	10.1	8.0	12.9	8.7	8.2	10.8	6.9	10.9	8.0	8.2	8.5	10.3	11.0	12.0	7.6	7.1	14.3	6.0	8.8	9.0	7.6	12.3	10.0	26.5	8.4	9.7	11.8	10.9	11.6	9.3	6.4	9.0	13.2	15.3	20.6	14.5	17.2	12.2	15.3	20.5	11.8	15.2	19.2	20.7	24.8	23.4	17.8	15.4	29.1	16.3	11.5	23.0	22.2	10.1	11.1	8.7	15.3	11.1	15.4	12.6	11.9	14.5	16.5	13.5	14.8	13.3	19.5	15.2	8.1	17.4	24.5	12.9	12.5	11.0	6.1	18.3	18.9	11.2	17.9	12.9	32.6	18.2	15.9	11.9	13.8	14.1	19.7	16.1	36.0	12.8	14.7	22.3	18.3	11.6	18.6	16.7	19.4	11.3	14.0	17.7	18.1	40.9	22.3	30.8	19.3	24.6	23.0	35.4	23.2	24.4	16.1	34.5	34.4	24.8	19.3	26.1	35.7	15.0	28.3	22.2	7.9	8.3	9.9	11.1	8.3	8.4	8.7	8.2	8.5	7.6	8.4	9.0	12.3	9.6	10.1	6.2	17.1	7.1	14.8	52.4	7.4	22.7	9.6	11.3	20.8	10.0	26.6	23.9	22.9	38.0	10.7	15.3	52.8	28.0	314.5	10.7	12.9	12.3	11.4	17.7	9.1	18.7	22.9	14.4	13.3	9.4	20.3	15.7	16.4	9.4	22.8	18.5	9.5	12.0	32.6	19.9	12.0	289.0	18.6	13.8	3.6	5.6	20.4	22.0	35.0	4.5	10.7	18.9	14.1	16.6	11.8	11.3	16.1	40.2	21.7	14.3	6.6	10.5	18.1	112.9	43.0	7.5	6.0	30.5	16.1	22.4	11.5	14.2
MKNK2	"GPRK7, MNK2"	ENSG00000099875	"MAPK interacting serine/threonine kinase 2"	Q9HBH9	19	2037465-2051244	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Translation regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 475.7;tongue: 551.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 367.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021875, CAB037253, HPA070499"	Supported		Supported	"Nuclear bodies"		No	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear bodies"		"CAB037253: AB_1079401, HPA021875: AB_1854050, HPA070499: AB_2732157"	"unprognostic (8.76e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (4.86e-5)"	"unprognostic (3.08e-1)"	"unprognostic (1.59e-2)"	"unprognostic (6.42e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.32e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.07e-2)"	"prognostic favorable (4.01e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.59e-1)"	87.2	50.2	70.5	51.3	78.0	133.6	39.5	109.2	131.2	41.9	80.6	55.2	47.4	24.7	47.8	114.5	38.1	26.7	54.8	67.2	65.4	27.6	71.2	51.8	66.8	80.3	70.7	34.5	191.9	34.5	39.6	35.3	74.6	38.6	30.0	35.7	133.8	39.7	475.7	63.8	57.3	21.8	68.2	80.2	55.1	21.6	75.7	34.5	54.6	551.1	58.6	39.9	60.9	91.0	64.9	71.8	30.1	66.3	219.5	79.0	65.1	37.3	27.1	26.5	26.8	45.5	111.8	88.2	50.7	77.4	27.9	78.4	38.4	110.9	12.0	122.1	34.4	36.8	62.1	49.2	367.4	72.3	61.6	84.1	262.0	50.8	107.2	61.9	63.5	59.2	62.0	155.4	18.6	37.7	42.8	59.3	78.6	49.6	78.1	81.8	8.6	113.1	48.1	41.2	39.9	48.2	89.0	125.1	166.4	33.5	52.7	89.5	96.5	9.5	37.5	38.5	46.0	238.9	97.0	85.7	78.2	53.5	17.9	4.4	9.2	9.8	8.1	10.2	7.5	16.9	8.4	9.4	7.7	15.0	5.4	6.6	41.7	9.5	13.6	9.2	12.5	3.6	70.5	78.0	109.2	131.2	67.2	65.4	80.3	70.7	74.6	68.2	75.7	91.0	102.2	38.5	56.5	9.8	91.4	82.5	105.6	84.5	50.1	55.7	99.0	103.5	54.5	38.6	65.5	36.8	25.0	23.5	106.5	155.3	9.8	27.3	8.7	60.2	28.0	51.9	150.2	80.2	5.6	56.6	47.2	45.0	57.6	76.2	29.2	14.5	82.5	60.3	36.9	42.1	5.9	104.1	46.8	52.5	134.6	13.0	20.2	68.0	56.9	8.4	41.8	63.6	30.9	6.0	5.2	47.2	86.6	20.3	55.4	94.2	98.8	18.6	55.2	47.5	19.7	132.6	48.7	18.1	19.5	97.8	117.2	56.5	69.3	18.1	79.7	114.0
MSH3	"DUP, MRP1"	ENSG00000113318	"MutS homolog 3"	P20585	5	80654652-80876815	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 95.1;Inhibitory neurons: 98.9;Oligodendrocytes: 92.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036081			Approved	"Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear bodies"		"HPA036081: AB_10673229"	"unprognostic (1.91e-1)"	"unprognostic (7.61e-2)"	"prognostic favorable (5.90e-5)"	"unprognostic (2.95e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.70e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.91e-1)"	"prognostic favorable (1.77e-4)"	"unprognostic (5.15e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.29e-1)"	9.4	4.6	1.8	4.3	2.4	5.0	5.5	1.6	2.0	6.6	1.5	6.0	6.0	5.2	5.3	5.0	7.0	5.7	4.9	1.7	2.0	12.5	11.4	4.2	4.9	1.7	2.0	5.3	5.2	8.8	3.3	4.3	1.7	5.2	6.2	3.7	4.5	5.2	5.1	5.1	5.6	5.1	2.2	4.1	5.0	3.9	2.5	7.1	10.8	4.7	6.1	6.3	3.9	2.0	12.4	15.0	11.7	13.1	6.6	12.3	16.6	12.2	11.8	13.6	16.7	10.0	15.6	22.2	14.0	15.3	12.8	10.4	15.6	20.5	17.3	14.2	13.9	8.4	13.4	9.9	6.8	9.9	8.5	10.9	9.5	15.8	16.6	13.8	12.9	7.9	12.1	12.9	16.1	11.9	19.0	4.7	9.0	4.8	7.7	13.2	24.2	16.4	15.2	13.0	11.6	13.9	10.4	11.5	13.0	14.4	15.2	9.4	12.4	7.8	9.5	6.2	23.0	8.7	15.6	21.6	12.2	16.8	10.2	0.7	2.9	1.9	3.3	3.4	3.8	3.4	3.5	3.6	3.3	2.2	2.6	2.6	1.7	3.1	4.6	2.8	4.8	2.4	1.8	2.4	1.6	2.0	1.7	2.0	1.7	2.0	1.7	2.2	2.5	2.0	16.7	35.3	9.3	66.9	18.1	10.5	12.3	12.4	12.5	25.8	19.4	12.8	17.6	8.6	14.3	14.7	14.6	18.9	18.7	18.2	15.6	12.4	14.6	28.4	20.2	12.0	14.5	17.0	95.1	10.3	12.9	15.9	31.6	18.9	8.2	19.9	10.0	20.1	11.5	21.9	98.9	13.2	8.2	13.0	7.0	17.2	13.7	16.3	3.6	72.1	19.9	22.5	19.6	71.9	92.3	10.6	9.6	25.9	22.0	6.5	16.8	43.6	65.4	28.3	19.7	20.2	14.7	24.7	25.5	22.3	10.1	13.1	25.4	14.7	17.4	10.7
NFIL3	"E4BP4, IL3BP1, NF-IL3A, NFIL3A"	ENSG00000165030	"Nuclear factor, interleukin 3 regulated"	Q16649	9	91409045-91423832	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 122.0;Endometrial stromal cells: 127.4;Glandular and luminal cells: 152.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 57.9;neutrophil: 26.9"	"Lineage enriched"	"Detected in many"	35	"granulocytes: 57.9"	"Cell line enhanced"	"Detected in all"		"ASC diff: 152.6;HDLM-2: 179.1;hTCEpi: 141.2;hTERT-HME1: 149.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003261	Approved		Approved	"Nuclear bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	"Nuclear bodies"		"HPA003261: AB_1079477"	"unprognostic (2.18e-1)"	"unprognostic (7.30e-2)"	"unprognostic (4.81e-2)"	"unprognostic (5.17e-3)"	"unprognostic (2.13e-1)"	"unprognostic (4.91e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.54e-2)"	"unprognostic (6.45e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (3.23e-6)"	"unprognostic (5.44e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.37e-2)"	149.8	84.1	11.1	37.5	12.1	211.2	80.2	16.5	17.0	75.6	14.0	55.3	18.1	62.0	15.0	22.9	94.0	47.5	60.9	11.9	13.8	36.2	121.6	68.7	9.4	15.7	14.6	92.6	30.3	15.9	31.6	47.4	14.7	59.9	21.8	33.6	22.9	16.4	133.5	59.5	29.3	52.5	13.2	20.0	44.1	18.5	13.7	18.2	26.7	24.9	11.6	61.2	64.9	12.9	18.3	10.7	12.8	7.1	152.6	117.9	62.1	21.3	61.1	23.8	35.8	7.4	8.9	7.9	12.9	17.8	69.5	11.7	14.9	21.4	27.1	179.1	6.4	8.7	10.2	62.2	124.4	12.1	50.8	120.3	141.2	21.5	149.2	13.5	10.8	20.2	14.3	89.6	15.8	9.2	1.3	16.1	9.8	31.3	9.7	29.3	13.9	11.7	29.5	8.7	16.0	11.8	14.9	13.2	21.5	22.6	7.4	15.8	11.6	52.0	11.5	45.2	10.9	76.3	18.9	3.5	27.8	11.3	9.4	57.9	1.6	10.3	1.2	0.7	0.6	0.4	0.0	0.3	0.9	0.1	0.1	0.2	26.9	0.1	1.0	0.6	0.0	0.6	11.1	12.1	16.5	17.0	11.9	13.8	15.7	14.6	14.7	13.2	13.7	12.9	60.1	22.4	32.4	1.3	7.8	46.1	14.7	15.2	22.2	17.7	31.7	28.6	81.8	8.6	16.4	0.0	16.7	9.6	75.6	23.7	9.8	10.5	24.1	122.0	127.4	34.3	16.1	1.3	5.1	9.8	24.9	55.0	9.7	152.6	9.5	27.5	13.9	29.4	10.6	20.2	5.6	9.5	6.1	25.3	78.0	6.4	10.8	75.4	33.8	2.8	15.4	17.8	6.2	3.5	2.9	7.8	9.1	11.7	24.3	25.6	17.7	10.0	10.3	15.5	6.6	60.2	83.8	0.8	3.9	23.3	39.5	23.1	22.6	6.8	9.6	13.1
NKX2-4	"NKX2.4, NKX2D"	ENSG00000125816	"NK2 homeobox 4"	Q9H2Z4	20	21395365-21397526	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 4.3;testis: 1.2"	"Group enriched"	"Detected in some"	24	"Cardiomyocytes: 1.3;Early spermatids: 3.0;Late spermatids: 2.7;Spermatocytes: 3.8;Spermatogonia: 1.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"hypothalamus: 3.4;thalamus: 4.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.5;HEK 293: 5.1;SCLC-21H: 3.2;SK-MEL-30: 4.2;WM-115: 1.2"	"Region enriched"	"Detected in single"	23	"hypothalamus: 2.7"	"Region enriched"	"Detected in single"	11	"hypothalamus: 1.1"	HPA074996			Approved	"Nuclear bodies"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear bodies"		"HPA074996: AB_2686725"					"unprognostic (3.77e-1)"				"unprognostic (2.15e-1)"						"unprognostic (1.68e-1)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	3.2	0.0	0.0	0.0	4.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.4	0.1	0.2	0.1	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.8	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NOP10	"MGC70651, NOLA3, NOP10P"	ENSG00000182117	"NOP10 ribonucleoprotein"	Q9NPE3	15	34341719-34343136	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	Ribonucleoprotein	"Disease variant, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 878.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059198	Supported		Supported	"Nuclear bodies"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 52: Non-specific - Ribosome"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 10: Non-specific - Unknown function"	"Nuclear bodies"		"HPA059198: AB_2683945"	"unprognostic (2.65e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (1.48e-5)"	"unprognostic (3.12e-1)"	"unprognostic (2.39e-3)"	"unprognostic (8.11e-3)"	"unprognostic (9.99e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.31e-3)"	"unprognostic (1.77e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.83e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.05e-1)"	"unprognostic (6.77e-3)"	154.9	145.7	119.9	104.8	122.2	208.3	151.7	124.3	149.6	118.6	120.1	164.3	109.3	91.9	285.5	175.0	120.0	90.2	179.4	120.7	129.1	167.7	241.1	148.0	146.2	125.3	123.2	63.3	90.4	142.5	90.5	126.8	125.6	98.2	202.1	48.4	93.6	102.2	184.4	114.4	110.2	163.6	125.1	167.5	119.0	41.7	132.7	213.2	112.8	227.4	218.6	213.6	121.2	132.8	212.2	471.9	325.1	205.3	520.4	443.7	172.4	281.3	471.8	555.4	703.6	358.5	200.3	146.7	328.6	457.7	627.3	292.8	599.1	502.8	526.0	216.0	341.7	461.6	396.5	523.7	724.2	303.2	228.6	513.8	471.0	508.3	588.1	305.0	795.6	399.9	417.0	206.4	695.3	295.8	234.0	486.1	319.8	628.7	453.3	252.2	223.4	241.8	754.0	475.5	210.4	279.5	202.1	211.7	221.4	442.9	235.4	619.4	331.2	295.3	219.6	418.2	242.7	198.9	427.1	406.8	377.5	495.8	214.5	1080.4	852.4	889.6	368.7	867.8	394.9	723.0	476.7	442.7	636.3	639.5	503.6	441.2	2797.7	534.1	696.7	824.6	700.1	1065.2	119.9	122.2	124.3	149.6	120.7	129.1	125.3	123.2	125.6	125.1	132.7	132.8	202.7	109.0	153.3	7.2	175.1	239.5	179.8	470.8	130.3	30.9	158.6	195.2	299.7	143.0	273.9	149.0	12.5	210.7	158.0	286.1	446.1	365.6	15.0	230.7	148.1	257.5	195.7	169.5	6.7	351.9	402.1	154.2	122.9	234.0	164.0	81.3	240.9	359.7	878.9	13.5	7.1	283.9	315.3	504.5	321.5	16.8	103.8	309.2	190.3	12.2	322.1	70.0	250.3	5.0	10.0	600.6	362.9	100.1	209.5	251.2	304.2	668.9	298.6	33.7	105.2	91.7	336.0	19.0	101.8	224.8	302.8	214.0	154.2	128.7	241.0	451.3
NR1D1	"ear-1, hRev, Rev-ErbAalpha, REVERBA, REVERBalpha, THRA1, THRAL"	ENSG00000126368	"Nuclear receptor subfamily 1 group D member 1"	P20393	17	40092793-40100589	"Metabolic proteins, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 325.5"	"Cell type enhanced"	"Detected in all"		"Squamous epithelial cells: 95.5;Suprabasal keratinocytes: 81.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 18.5"	"Group enriched"	"Detected in many"	6	"monocytes: 5.5;T-cells: 18.5"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 60.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007935	Uncertain		Supported	"Nuclear bodies"		NA	Yes			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nuclear bodies"		"HPA007935: AB_10601277"	"unprognostic (1.38e-2)"	"unprognostic (3.46e-2)"	"prognostic unfavorable (1.94e-4)"	"unprognostic (2.53e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (1.36e-4)"	"unprognostic (1.93e-3)"	"unprognostic (9.93e-3)"	"unprognostic (2.73e-1)"	"unprognostic (9.15e-3)"	"unprognostic (4.54e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.34e-1)"	72.3	53.7	23.5	6.3	27.0	5.4	63.1	52.9	49.7	109.6	10.6	53.3	14.3	35.8	4.5	42.5	27.7	7.1	60.8	24.9	17.2	38.0	43.2	49.2	9.3	18.1	20.9	71.3	24.3	9.0	32.0	6.0	15.9	40.5	4.0	50.4	52.9	16.3	99.0	325.5	23.0	7.5	12.9	11.6	31.5	12.5	34.0	6.3	32.1	38.1	5.4	42.5	96.5	25.2	5.5	7.8	1.6	6.2	9.0	6.2	2.2	11.9	19.5	3.9	4.9	5.1	19.5	6.7	6.9	13.8	12.9	15.4	4.1	18.0	2.9	5.6	4.1	4.8	7.9	13.5	14.6	7.2	6.9	13.5	12.8	13.3	28.2	12.6	4.9	7.7	7.2	60.6	3.8	3.8	10.7	6.1	3.0	10.8	12.3	7.5	2.2	20.7	5.4	4.9	5.1	2.9	7.6	9.7	12.4	2.7	4.6	5.8	4.7	17.2	16.7	14.1	9.5	21.5	35.7	2.6	23.4	4.0	13.6	0.0	0.5	0.0	4.4	2.0	18.5	1.7	5.5	6.4	1.1	2.1	4.8	3.5	0.2	1.0	5.5	1.4	8.0	1.8	23.5	27.0	52.9	49.7	24.9	17.2	18.1	20.9	15.9	12.9	34.0	25.2	16.4	3.2	2.0	17.3	5.7	64.5	47.5	20.5	67.2	71.4	9.4	15.1	5.7	8.6	11.9	1.8	4.2	2.6	4.9	26.0	7.9	16.1	2.3	25.4	30.6	18.6	8.3	3.6	7.1	11.8	1.2	26.5	31.1	64.2	2.5	2.7	6.8	31.8	2.5	42.1	6.2	7.2	8.2	3.4	19.4	1.5	21.8	7.7	19.6	8.4	1.2	39.0	5.2	5.0	1.2	26.0	14.7	38.7	10.5	35.4	58.8	7.9	5.0	29.7	6.6	9.6	19.4	2.0	11.1	95.5	81.1	2.3	11.9	13.7	6.0	28.7
NR2E1	"TLL, TLX, XTLL"	ENSG00000112333	"Nuclear receptor subfamily 2 group E member 1"	Q9Y466	6	108166022-108188805	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	57	"brain: 19.7;choroid plexus: 14.3;retina: 30.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 22.2;Inhibitory neurons: 8.5;Muller glia cells: 44.9;Oligodendrocyte precursor cells: 4.5"	"Cancer enriched"	"Detected in single"	14	"glioma: 6.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.0;GAMG: 1.4;HEK 293: 1.0;U-251 MG: 4.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA036954, HPA055642"	Uncertain		Approved	"Nuclear bodies"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 5: Muller glia cells - Visual perception"	"Nuclear bodies"		"HPA036954: AB_10670958, HPA055642: AB_2682871"	"unprognostic (3.43e-1)"	"unprognostic (1.41e-1)"			"unprognostic (1.77e-1)"	"unprognostic (9.60e-2)"	"unprognostic (6.27e-2)"	"unprognostic (6.00e-1)"	"unprognostic (1.78e-2)"		"unprognostic (7.31e-2)"	"unprognostic (8.64e-2)"	"unprognostic (9.59e-8)"	"unprognostic (2.87e-1)"	"unprognostic (2.49e-1)"		"unprognostic (3.07e-1)"	0.0	0.3	16.9	0.0	19.7	0.0	0.0	7.3	18.6	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	14.3	0.1	0.0	0.0	0.0	7.4	13.0	0.0	0.0	0.0	0.2	0.0	7.8	0.0	0.0	30.6	0.1	0.0	0.0	0.1	0.0	0.0	7.2	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	19.7	7.3	18.6	16.6	14.3	7.4	13.0	7.8	7.2	16.4	12.9	0.0	0.0	0.0	22.2	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.9	0.0	4.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NUP210L		ENSG00000143552	"Nucleoporin 210 like"	Q5VU65	1	153992685-154155116	"Cancer-related genes, Metabolic proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"testis: 26.6"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 20.3;Inhibitory neurons: 8.4;Late spermatids: 8.5;Oligodendrocytes: 19.2;Spermatocytes: 28.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	47	"MCF7: 15.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA047195, HPA064245, HPA066707"	Enhanced		Approved	"Nuclear bodies"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear bodies"		"HPA047195: AB_2679980, HPA064245: AB_2685224, HPA066707: AB_2685706"	"unprognostic (2.11e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.72e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.79e-3)"	"unprognostic (3.45e-2)"	"unprognostic (5.57e-2)"	"unprognostic (4.51e-4)"	"unprognostic (1.15e-1)"	"unprognostic (9.35e-10)"	"unprognostic (4.20e-2)"	"unprognostic (3.78e-2)"	"unprognostic (7.45e-2)"	"unprognostic (4.09e-2)"	0.1	0.0	0.2	0.0	0.7	0.1	0.0	2.4	0.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.3	0.1	0.0	0.1	0.0	0.7	0.6	0.1	0.1	0.0	0.3	0.0	0.8	0.1	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.2	0.3	0.0	0.0	26.6	0.5	0.0	0.2	0.0	0.0	0.3	0.0	2.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	15.8	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.2	0.7	2.4	0.9	0.4	0.3	0.7	0.6	0.8	0.3	0.5	2.3	0.6	0.0	0.0	6.2	0.5	0.3	0.1	0.1	0.0	0.0	0.3	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	20.3	0.7	0.6	0.9	0.0	0.4	7.0	0.2	0.1	0.5	0.0	1.5	0.0	0.1	0.0	0.0	0.2	0.0	8.4	0.1	0.0	0.0	0.6	8.5	0.9	0.8	0.0	2.8	0.0	0.0	0.0	4.5	19.2	0.0	0.0	1.2	1.7	0.1	0.0	0.1	0.1	0.0	6.6	1.8	0.3	28.2	5.1	0.3	0.6	0.0	0.4	0.1	0.1	0.3
NUTM2A	FAM22A	ENSG00000184923	"NUT family member 2A"	Q8IVF1	10	87225448-87236908	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 10.2"									HPA064635			Approved	"Nuclear bodies"		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear bodies"		"HPA064635: "	"unprognostic (1.75e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.29e-2)"	"unprognostic (5.67e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.75e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.65e-1)"	1.4	1.1	1.8	0.5	2.6	0.9	1.1	0.8	2.8	0.9	0.0	1.3	0.7	1.4	0.9	0.9	1.0	0.5	2.2	1.2	1.7	1.3	1.3	1.1	0.6	3.2	2.2	1.3	1.7	1.4	1.5	0.7	2.5	1.6	0.5	0.6	2.4	0.4	1.3	1.8	1.2	0.4	1.1	1.3	1.5	2.0	2.9	1.0	1.5	1.6	0.3	1.1	1.2	4.4	1.4	0.1	0.8	0.0	1.3	0.6	0.7	0.6	1.3	0.6	0.4	0.3	0.6	1.2	0.1	0.0	0.2	1.1	0.0	0.9	0.1	0.4	1.0	2.0	0.3	0.3	0.6	0.8	10.2	0.4	3.2	1.0	1.0	1.2	0.0	1.9	1.9	0.3	0.1	1.0	1.0	2.0	2.3	0.0	0.3	1.5	0.1	0.0	0.4	0.1	1.2	2.0	0.6	0.5	0.5	0.1	0.6	0.8	1.4	0.0	0.3	0.6	0.2	0.0	0.2	0.6	0.6	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.6	0.8	2.8	1.2	1.7	3.2	2.2	2.5	1.1	2.9	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0
NUTM2B	"bA119F19.1, FAM22B"	ENSG00000188199	"NUT family member 2B"	A6NNL0	10	79703227-79714681	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"											HPA064635			Approved	"Nuclear bodies"		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nuclear bodies"		"HPA064635: "	"unprognostic (9.51e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.63e-1)"	"unprognostic (6.60e-2)"	"unprognostic (2.47e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.95e-1)"	"unprognostic (7.79e-3)"	"unprognostic (1.15e-1)"	"unprognostic (9.70e-2)"	"unprognostic (9.97e-2)"	"unprognostic (5.72e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.32e-2)"	0.6	0.7	1.6	0.7	1.3	1.4	0.6	3.1	1.9	0.6	0.0	0.8	0.2	0.8	0.5	0.6	0.9	0.2	1.5	1.7	0.9	1.6	1.1	0.8	0.7	1.6	0.9	0.9	1.4	0.7	1.8	0.3	1.5	1.1	0.2	0.8	1.0	0.3	1.0	1.1	0.9	0.1	0.3	1.3	0.9	3.4	1.8	0.7	0.9	0.1	0.7	0.5	0.8	1.8	0.7	0.8	1.7	1.0	0.4	0.4	0.7	0.3	0.5	0.4	0.4	0.1	1.5	1.7	0.2	0.4	0.6	0.7	0.1	0.8	0.3	1.1	0.6	1.3	0.2	0.5	0.7	1.2	2.9	1.1	0.4	0.2	0.3	1.5	0.0	2.4	1.9	0.8	0.3	1.4	0.3	2.3	1.6	0.0	0.8	0.4	0.2	0.2	0.5	0.2	0.7	1.8	1.0	1.3	1.7	0.8	0.4	1.4	1.0	0.2	0.3	0.2	0.6	0.3	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.3	3.1	1.9	1.7	0.9	1.6	0.9	1.5	0.3	1.8	1.8	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1
NUTM2D	FAM22D	ENSG00000214562	"NUT family member 2D"	Q5VT03	10	87357720-87370695	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.2;Cone photoreceptor cells: 4.2;Gastric mucus-secreting cells: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 12.4;hTCEpi: 11.7"									HPA064635			Approved	"Nuclear bodies"		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nuclear bodies"		"HPA064635: "	"unprognostic (2.13e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.69e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.35e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.57e-1)"	"unprognostic (7.76e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.32e-1)"	3.1	3.0	5.3	1.4	7.2	2.4	3.1	4.5	8.4	2.4	0.2	3.6	2.1	3.0	3.4	2.8	3.1	2.6	5.6	4.5	4.9	4.8	4.2	3.3	2.1	8.1	7.0	3.7	4.7	4.1	4.8	2.5	7.0	4.5	2.0	2.7	3.9	2.0	3.8	4.7	3.2	1.3	3.6	3.7	4.0	4.9	7.1	2.5	4.5	2.9	1.6	3.1	3.1	10.5	3.9	2.8	6.1	0.0	1.6	2.3	1.4	1.0	5.0	2.2	2.5	1.8	1.9	3.3	0.9	1.7	1.0	1.8	0.1	2.0	1.0	2.2	2.7	4.9	0.2	2.8	3.8	3.1	12.4	3.7	11.7	2.5	1.9	3.4	2.2	4.3	5.2	0.8	0.5	3.5	2.4	5.2	3.4	0.8	0.3	3.3	0.4	0.1	2.2	0.8	2.4	3.7	1.1	2.6	1.2	2.3	4.9	2.4	5.5	1.5	1.0	1.4	1.8	4.0	2.4	0.9	0.9	1.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	7.2	4.5	8.4	4.5	4.9	8.1	7.0	7.0	3.6	7.1	10.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.9	0.3	0.3	1.2	0.0	0.0	0.0	4.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.4	0.1	0.0	0.0	0.2	1.1	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.1
NUTM2E	FAM22E	ENSG00000228570	"NUT family member 2E"	B1AL46	10	79841358-79850878	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 1.2;Exocrine glandular cells: 1.0;Pancreatic endocrine cells: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 2.0;NB-4: 1.6;U-266/84: 1.2"									HPA064635			Approved	"Nuclear bodies"		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Nuclear bodies"		"HPA064635: "	"unprognostic (2.82e-1)"	"unprognostic (3.95e-1)"		"unprognostic (1.90e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.19e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.66e-1)"	"unprognostic (4.35e-1)"	"unprognostic (4.09e-1)"	0.1	0.1	0.6	0.0	0.5	0.1	0.1	1.0	0.6	0.2	0.1	0.1	0.2	0.2	0.6	0.1	0.2	0.1	0.2	0.6	0.4	0.3	0.2	0.2	0.3	0.5	0.5	0.2	0.3	0.0	0.5	0.1	0.4	0.2	0.1	0.2	0.1	0.2	0.1	0.2	0.2	0.1	0.3	0.3	0.1	0.7	0.5	0.5	0.3	0.3	0.0	0.1	0.1	0.6	0.0	0.5	0.0	0.3	0.0	0.0	0.1	0.0	0.5	0.2	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.5	2.0	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.6	1.6	0.0	0.4	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.7	1.2	0.1	0.3	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	1.0	0.6	0.6	0.4	0.5	0.5	0.4	0.3	0.5	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.1	1.2	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0
NUTM2F	"DKFZp434I1117, FAM22F"	ENSG00000130950	"NUT family member 2F"	A1L443	9	94318196-94328644	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	12	"testis: 1.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 10.4;Excitatory neurons: 42.9;Inhibitory neurons: 29.0;Microglial cells: 11.2;Oligodendrocyte precursor cells: 27.2;Oligodendrocytes: 31.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"NTERA-2: 1.3"									HPA064635			Approved	"Nuclear bodies"		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear bodies"		"HPA064635: "	"unprognostic (1.40e-1)"	"unprognostic (4.93e-3)"	"unprognostic (4.16e-2)"			"unprognostic (1.47e-1)"	"unprognostic (9.26e-3)"	"unprognostic (1.03e-1)"		"unprognostic (2.21e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.72e-3)"	"unprognostic (8.48e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.14e-1)"		"unprognostic (1.83e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	27.2	31.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NUTM2G	FAM22G	ENSG00000188152	"NUT family member 2G"	Q5VZR2	9	96928310-96940253	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 2.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.2;Oligodendrocyte precursor cells: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.8;HeLa: 1.7;SiHa: 1.7"									HPA064635			Approved	"Nuclear bodies"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nuclear bodies"		"HPA064635: "	"unprognostic (2.80e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.49e-3)"	"unprognostic (7.78e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.50e-3)"	"unprognostic (2.31e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.52e-2)"	0.1	0.2	0.7	0.1	1.0	0.6	0.1	1.3	0.9	0.3	0.2	0.2	0.1	0.2	0.0	0.4	0.1	0.2	0.2	0.8	0.5	0.3	0.1	0.3	0.3	0.8	0.4	0.4	0.3	0.0	0.2	0.1	0.5	0.3	0.0	0.2	0.4	0.0	0.7	0.8	0.2	0.0	0.1	0.3	0.2	2.9	0.8	0.0	0.3	0.0	0.0	0.2	0.3	1.3	0.6	0.5	0.4	0.8	0.0	0.0	0.6	0.2	0.0	0.0	0.0	1.8	0.2	0.6	0.1	0.0	0.5	0.8	0.0	0.0	0.0	0.4	0.7	0.6	1.7	0.8	0.0	0.9	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.9	0.4	0.0	1.0	0.3	0.7	0.9	0.6	0.4	0.4	0.6	0.0	0.0	0.6	0.7	0.2	1.7	0.2	0.1	0.2	0.1	0.0	0.4	0.9	0.3	0.3	0.3	0.2	0.0	0.3	0.1	0.2	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	1.0	1.3	0.9	0.8	0.5	0.8	0.4	0.5	0.1	0.8	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.2	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
PGP		ENSG00000184207	"Phosphoglycolate phosphatase"	A6NDG6	16	2211593-2214840	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 52.2"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 404.5;Early spermatids: 480.5;Late spermatids: 1591.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043096, HPA046739"	Approved		Approved	"Nuclear bodies"		NA	NA		250000	"Cluster 52: Eosinophils - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear bodies"		"HPA043096: AB_2678311, HPA046739: AB_2679779"	"unprognostic (8.33e-2)"	"unprognostic (4.77e-3)"	"unprognostic (2.36e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.76e-1)"	"unprognostic (5.75e-3)"	"unprognostic (5.87e-2)"	"unprognostic (7.90e-2)"	"unprognostic (4.43e-3)"	"unprognostic (6.50e-2)"	"unprognostic (9.04e-2)"	"prognostic favorable (7.05e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (6.42e-4)"	7.5	11.8	17.3	6.1	17.6	8.3	7.6	19.5	26.9	6.4	10.6	11.2	6.0	8.7	4.7	6.9	7.2	3.2	33.0	16.3	13.3	14.0	11.5	10.0	6.4	26.8	15.2	4.7	7.8	5.6	11.9	5.3	27.6	8.3	3.8	7.8	7.3	4.8	41.1	7.8	11.5	3.4	12.6	13.7	10.3	52.2	15.7	5.5	16.1	18.0	3.8	8.6	5.4	17.8	16.2	26.0	18.9	17.5	7.3	6.1	35.4	18.5	8.6	16.5	17.0	40.3	20.0	12.3	17.7	8.5	13.5	26.7	12.7	15.7	7.4	17.0	35.3	12.4	44.3	18.4	4.9	21.8	19.6	6.8	7.0	15.6	5.7	6.3	10.9	20.0	22.4	12.7	9.3	44.1	25.1	35.7	24.1	9.8	23.9	40.9	16.3	27.5	13.9	10.1	24.1	14.8	16.8	29.8	13.1	13.4	22.9	25.3	10.9	17.6	22.5	15.9	18.7	30.1	13.9	17.8	5.8	19.2	13.7	0.0	0.8	2.5	0.7	1.2	0.1	0.2	0.4	0.5	0.5	0.8	0.2	0.4	0.6	0.1	1.2	0.7	0.5	0.2	17.3	17.6	19.5	26.9	16.3	13.3	26.8	15.2	27.6	12.6	15.7	17.8	35.0	6.4	7.8	17.6	20.9	23.3	7.8	2.6	4.0	196.1	31.1	33.8	40.7	17.2	5.7	40.5	404.5	121.1	44.8	63.6	58.7	10.4	480.5	28.5	22.5	24.7	29.8	38.3	38.0	14.0	107.1	20.3	28.5	27.7	10.2	54.1	20.3	39.2	58.0	144.7	30.9	37.3	2.0	33.1	64.8	1591.0	25.7	37.9	35.6	7.5	20.2	63.4	42.2	11.6	21.9	14.4	32.5	28.2	36.9	21.9	34.8	39.4	3.4	220.6	39.5	19.3	94.3	162.9	64.8	12.7	31.8	54.5	30.0	70.8	50.5	15.2
PLXDC2	"FLJ14623, TEM7R"	ENSG00000120594	"Plexin domain containing 2"	Q6UX71	10	19816239-20289856	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Microglial cells: 1508.4;Oligodendrocytes: 470.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 57.5;intermediate monocyte: 33.4;myeloid DC: 36.0;neutrophil: 81.6;non-classical monocyte: 37.3"	"Group enriched"	"Detected in many"	13	"dendritic cells: 36.0;granulocytes: 81.6;monocytes: 57.5"	"Cell line enhanced"	"Detected in some"		"HHSteC: 19.4;U-2197: 45.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017268, HPA070793"	Approved		Supported	"Nuclear bodies"		No	No		720000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear bodies"		"HPA017268: AB_10965928, HPA070793: AB_2686313"	"unprognostic (1.75e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.05e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.32e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.44e-2)"	"unprognostic (3.91e-3)"	"unprognostic (8.71e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.66e-2)"	12.4	9.4	13.3	7.3	14.1	5.2	11.5	9.6	13.3	12.7	16.8	5.3	4.2	10.7	3.5	7.5	10.1	17.4	10.2	11.3	25.6	10.7	3.1	17.1	2.4	18.0	17.3	9.4	3.6	16.2	3.3	4.7	19.2	7.6	4.6	18.2	6.2	7.7	5.0	15.5	7.1	16.2	16.2	9.4	3.8	5.9	22.3	2.5	6.8	10.0	2.8	8.5	8.9	29.1	0.0	0.0	5.8	0.0	0.0	0.0	6.7	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	7.7	2.2	1.8	0.0	0.0	0.7	2.8	8.6	0.4	19.4	0.0	0.0	7.7	0.6	0.0	2.3	8.9	0.0	0.0	0.1	1.7	0.9	1.1	0.6	0.1	3.4	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.4	0.2	2.4	0.4	0.0	1.8	0.8	0.9	0.0	7.6	3.9	45.9	0.0	0.1	0.0	0.0	3.5	0.1	0.0	10.7	57.5	11.8	1.3	33.4	2.7	0.0	0.0	0.3	36.0	0.0	0.0	0.0	81.6	4.4	37.3	1.6	0.0	17.7	13.3	14.1	9.6	13.3	11.3	25.6	18.0	17.3	19.2	16.2	22.3	29.1	101.4	16.0	8.9	131.9	2.6	36.8	23.8	12.3	41.5	44.2	14.4	45.3	10.9	15.7	10.9	5.5	8.4	0.9	2.9	7.1	0.0	6.9	2.9	16.5	7.6	45.3	3.0	10.5	190.9	0.0	8.1	97.2	1.1	19.4	31.6	80.9	82.1	4.2	94.3	1.7	59.9	27.3	8.2	91.3	46.3	2.1	19.3	147.7	7.2	1508.4	94.5	25.5	5.2	158.3	470.2	1.0	16.6	57.2	3.8	5.5	16.0	22.2	3.0	73.6	19.7	110.1	12.7	1.6	1.2	35.5	38.1	1.2	4.2	71.4	8.8	11.7
PML	"MYL, RNF71, TRIM19"	ENSG00000140464	"PML nuclear body scaffold"	P29590	15	73994673-74047827	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Apoptosis, Biological rhythms, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Transferase"	"Cancer-related genes, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 127.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008312, CAB010194, CAB016304"	Supported		Enhanced	"Nuclear bodies"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear bodies"		"CAB010194: AB_2166848, CAB016304: AB_628162, HPA008312: AB_1079643"	"prognostic favorable (3.24e-4)"	"unprognostic (4.83e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.58e-3)"	"unprognostic (7.53e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.35e-2)"	"unprognostic (5.30e-3)"	"unprognostic (4.54e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (3.29e-4)"	"unprognostic (2.67e-2)"	"prognostic unfavorable (6.27e-8)"	"unprognostic (1.58e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.99e-2)"	84.4	29.4	14.4	25.6	13.8	38.1	77.0	11.8	16.4	53.7	11.6	46.7	18.4	47.1	7.5	38.3	44.6	21.6	39.3	13.8	13.1	35.4	25.4	75.2	25.6	18.2	13.8	37.5	20.3	8.3	26.8	23.7	14.8	41.5	8.5	3.9	44.2	17.2	22.5	47.4	39.0	19.5	14.6	48.6	35.3	11.3	15.2	17.0	48.1	7.9	15.2	42.7	44.5	13.1	37.2	13.8	11.8	11.4	30.2	43.2	40.6	18.5	31.6	55.9	63.3	14.6	64.2	16.4	63.7	31.6	53.3	66.6	16.3	37.1	7.6	58.0	25.1	35.8	21.3	16.3	36.9	33.9	31.1	83.7	24.8	37.5	19.2	39.3	38.3	26.1	30.6	28.3	32.7	17.3	28.3	52.6	12.8	7.7	25.0	21.6	13.4	30.8	60.3	59.5	10.1	11.1	29.7	16.3	44.8	10.3	12.8	28.7	66.1	56.6	15.5	28.5	38.1	29.4	20.0	8.0	38.9	42.2	18.2	7.4	14.7	23.4	13.0	20.2	9.8	12.4	10.4	14.1	14.5	10.2	8.2	8.5	12.0	14.5	22.6	9.2	14.3	10.1	14.4	13.8	11.8	16.4	13.8	13.1	18.2	13.8	14.8	14.6	15.2	13.1	127.8	16.0	12.2	8.8	24.9	22.9	14.3	30.4	37.5	8.1	13.5	12.8	10.0	5.7	16.7	5.5	2.1	9.4	18.8	13.1	7.9	25.8	3.4	16.0	16.7	48.0	14.3	29.3	4.7	19.1	15.0	20.7	58.1	26.0	12.0	11.5	32.2	11.3	30.8	8.4	4.8	14.3	14.2	20.1	18.5	4.0	27.7	19.6	7.2	7.5	24.6	8.5	20.6	4.5	6.0	62.8	15.5	24.0	21.6	26.2	22.8	10.4	18.3	5.4	39.5	7.7	20.4	1.1	4.0	27.1	19.6	4.9	20.4	16.8	12.1	26.0
PPM1M	"FLJ32332, PP2Ceta"	ENSG00000164088	"Protein phosphatase, Mg2+/Mn2+ dependent 1M"	Q96MI6	3	52245759-52250599	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 42.2;Kupffer cells: 39.0;Macrophages: 31.1;NK-cells: 30.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 54.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036905, HPA062291"	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear bodies"		"HPA036905: AB_10602818, HPA062291: AB_2684740"	"unprognostic (4.26e-3)"	"prognostic favorable (7.73e-4)"	"unprognostic (2.55e-2)"	"unprognostic (4.85e-3)"	"unprognostic (5.64e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.70e-2)"	"prognostic favorable (6.69e-4)"	"unprognostic (4.63e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.61e-5)"	"unprognostic (1.49e-1)"	"unprognostic (4.14e-2)"	"unprognostic (9.27e-2)"	"unprognostic (4.37e-2)"	19.5	9.4	12.7	20.3	13.7	24.6	15.5	9.9	13.6	25.9	12.2	18.7	6.0	18.3	9.9	12.3	18.1	14.1	11.4	13.6	14.2	10.9	5.6	23.5	29.6	12.8	11.4	18.6	8.0	11.2	9.1	11.6	12.2	16.7	8.7	2.2	11.6	15.2	3.7	10.7	13.1	18.0	12.0	30.1	11.4	8.8	15.5	27.6	13.8	7.8	28.2	17.5	18.2	12.9	0.9	5.4	3.2	7.6	46.1	45.7	5.2	12.2	26.2	17.0	13.1	3.2	4.2	9.0	3.6	32.0	9.5	1.5	10.9	2.3	6.9	11.0	2.7	20.5	14.6	3.3	33.6	3.1	18.7	37.8	5.2	18.9	11.9	27.3	22.2	40.5	3.6	14.5	20.2	2.2	13.7	0.9	4.1	4.0	14.7	3.0	1.6	20.0	7.3	2.6	2.3	9.3	9.0	2.2	11.1	6.8	7.6	7.9	15.5	6.5	10.7	3.8	1.6	54.3	11.2	9.9	12.7	5.4	8.0	1.8	24.1	13.3	20.6	19.3	15.9	6.8	16.1	19.2	14.4	7.4	15.2	19.0	28.9	11.7	29.6	8.5	20.5	17.5	12.7	13.7	9.9	13.6	13.6	14.2	12.8	11.4	12.2	12.0	15.5	12.9	6.8	0.0	5.4	1.3	15.4	5.1	6.5	0.7	8.0	1.6	5.9	7.2	1.8	5.7	2.0	1.8	0.0	3.3	25.9	0.7	3.9	1.8	9.7	4.7	8.9	7.0	1.2	3.0	1.5	1.1	5.8	11.9	3.1	11.0	5.7	7.3	12.5	3.7	42.2	1.7	0.6	0.4	2.0	39.0	17.0	18.0	12.8	31.1	5.4	4.7	29.1	5.1	30.9	1.5	0.7	1.3	3.2	9.8	11.4	2.3	0.9	3.0	0.9	0.7	19.7	5.2	7.3	0.7	4.2	11.9	3.8	1.9	25.1	3.1	1.0	3.5
PPWD1	KIAA0073	ENSG00000113593	"Peptidylprolyl isomerase domain and WD repeat containing 1"	Q96BP3	5	65563236-65587549	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019353, HPA019360"	Enhanced		Supported	"Nuclear bodies"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nuclear bodies"		"HPA019353: AB_1855668, HPA019360: AB_1855669"	"unprognostic (3.31e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.85e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (2.19e-4)"	"unprognostic (1.37e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.84e-3)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (6.72e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-2)"	15.0	12.1	12.3	18.2	14.6	27.6	17.2	16.5	16.4	17.3	13.4	14.7	13.4	19.0	17.8	13.5	16.1	15.7	13.5	12.4	13.2	13.0	15.5	14.9	30.0	13.6	12.8	22.9	14.0	15.5	14.7	19.6	13.4	15.0	19.2	14.7	12.7	13.7	13.2	22.2	17.1	13.2	12.9	22.6	14.4	18.1	13.0	32.9	16.3	15.6	26.0	13.7	15.2	18.5	36.5	23.6	35.1	35.2	30.6	36.9	38.8	34.5	25.3	36.5	45.5	37.8	35.4	41.5	28.5	24.3	49.1	32.3	38.4	35.5	49.8	35.7	32.3	26.0	40.0	31.1	25.9	23.9	26.4	29.2	15.3	35.5	25.5	27.0	32.3	31.6	35.3	28.8	28.8	35.8	40.0	31.6	24.7	15.2	13.3	35.4	46.7	35.1	21.2	29.5	18.1	14.8	34.8	14.5	33.1	26.8	21.5	30.8	24.9	20.2	29.2	22.4	52.9	17.1	26.3	45.5	22.3	35.8	21.4	35.0	15.1	31.6	26.1	19.3	32.0	25.8	29.1	29.9	21.2	19.1	36.1	31.0	14.3	26.5	24.0	11.8	38.1	23.4	12.3	14.6	16.5	16.4	12.4	13.2	13.6	12.8	13.4	12.9	13.0	18.5	25.1	28.9	22.4	28.1	36.0	12.4	14.9	15.4	18.2	14.2	9.1	12.8	19.8	7.2	22.1	11.0	8.4	27.7	27.0	6.9	9.8	8.7	76.8	16.4	28.7	20.7	9.6	21.5	37.2	7.7	14.4	21.1	15.8	13.8	11.4	32.6	18.9	6.0	11.8	6.7	46.8	14.9	8.2	16.4	11.9	41.7	20.2	15.2	14.2	23.4	22.6	11.8	23.7	42.3	67.1	8.9	14.7	18.8	29.4	6.6	10.0	7.9	17.8	20.9	6.6	19.9	17.8	32.5	33.7	13.2	11.8	25.2	35.4	15.8	11.4	9.0
RASL11A		ENSG00000122035	"RAS like family 11 member A"	Q6T310	13	27270830-27275192	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 29.6;Fibroblasts: 30.1;Gastric mucus-secreting cells: 42.3;Sertoli cells: 32.9;Smooth muscle cells: 112.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 1.3"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	4	"ASC diff: 42.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA004859, HPA053296"	Supported		Approved	"Nuclear bodies"		Yes	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear bodies"		"HPA004859: AB_2667270, HPA053296: AB_2682106"	"unprognostic (1.59e-1)"	"unprognostic (9.11e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.09e-2)"	"unprognostic (6.65e-2)"	"prognostic favorable (5.43e-4)"	"unprognostic (3.85e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.52e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.71e-2)"	"unprognostic (3.34e-1)"	32.9	4.1	1.9	3.1	3.2	2.3	21.8	3.1	3.1	21.4	2.1	20.4	7.7	21.6	3.9	9.8	22.0	3.8	11.3	3.2	1.7	30.4	12.9	13.0	10.8	1.8	2.2	9.5	4.9	1.4	10.6	2.9	2.0	20.3	12.5	0.1	5.3	5.6	3.5	10.1	20.9	5.5	2.2	14.8	13.4	2.9	3.3	1.2	12.1	1.7	10.0	19.1	15.9	2.4	0.3	1.3	0.3	0.6	42.4	4.3	0.2	1.9	1.8	0.1	0.1	8.1	0.8	0.3	0.5	1.4	0.9	0.1	2.5	0.8	0.1	1.7	8.8	1.8	0.2	0.5	6.8	0.6	0.6	5.0	0.7	0.1	0.1	1.7	0.6	0.7	0.3	0.1	0.0	0.8	0.0	2.4	1.5	8.0	10.2	0.5	0.0	0.2	1.4	6.2	0.7	0.3	0.7	3.3	0.2	1.0	0.2	0.8	0.3	0.1	0.3	2.9	0.4	0.1	0.0	0.0	0.4	1.9	0.1	0.4	0.4	0.4	0.0	0.5	0.1	0.1	0.0	0.0	0.2	1.2	0.1	0.1	0.2	0.1	1.3	0.1	0.0	0.1	1.9	3.2	3.1	3.1	3.2	1.7	1.8	2.2	2.0	2.2	3.3	2.4	29.6	16.0	11.2	0.3	6.0	4.6	3.2	0.9	17.6	0.0	6.2	11.9	1.4	0.0	8.6	7.3	0.0	0.7	4.5	9.3	3.9	1.8	0.0	5.1	9.8	5.9	0.0	4.0	0.6	2.4	0.2	30.1	42.3	6.1	0.0	2.1	2.5	0.2	1.4	0.0	0.6	5.6	4.1	0.8	6.5	0.0	0.3	6.1	1.8	1.9	1.7	0.3	0.0	0.5	1.8	0.5	12.7	1.5	17.1	1.1	11.4	1.7	10.3	0.2	32.9	11.6	112.0	0.0	0.0	13.5	4.4	0.8	4.5	1.2	6.7	1.1
RASL11B		ENSG00000128045	"RAS like family 11 member B"	Q9BPW5	4	52862317-52866835	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 27.6;ovary: 66.4"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 33.1;Cytotrophoblasts: 102.6;Extravillous trophoblasts: 62.2;Granulosa cells: 26.6;Peritubular cells: 68.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 14.1;CACO-2: 11.1;NTERA-2: 15.2;RPTEC TERT1: 10.2;SH-SY5Y: 38.5;SuSa: 10.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057803	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear bodies"		"HPA057803: AB_2683533"	"unprognostic (1.60e-1)"	"unprognostic (1.95e-1)"	"unprognostic (7.32e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.22e-1)"	"unprognostic (7.66e-2)"	"unprognostic (7.45e-3)"	"unprognostic (4.95e-2)"	"unprognostic (9.71e-2)"	"unprognostic (8.72e-2)"	"unprognostic (7.20e-4)"	"unprognostic (7.17e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.00e-6)"	"unprognostic (1.10e-1)"	2.0	2.0	3.1	0.5	3.8	0.0	1.1	2.8	5.8	4.5	0.1	0.9	0.0	9.8	2.7	0.5	4.1	0.9	14.7	5.2	3.2	17.9	0.6	1.0	0.8	0.3	0.4	66.4	0.9	7.9	0.7	4.7	0.2	2.0	0.1	0.3	1.4	9.1	0.4	3.8	0.9	1.9	0.2	27.6	4.1	5.9	1.4	0.1	1.0	0.1	0.9	2.2	4.9	3.2	0.3	0.0	5.9	0.0	5.2	2.4	14.1	0.1	0.1	0.3	0.0	11.1	0.0	0.0	0.5	0.0	0.1	0.0	0.7	3.5	0.0	0.0	1.4	0.5	0.0	0.0	1.0	0.0	0.4	2.5	6.2	0.0	0.2	0.0	0.0	0.3	0.7	0.0	0.0	1.3	1.1	0.0	15.2	1.3	0.2	0.0	6.8	0.0	10.2	1.5	3.2	38.5	0.2	2.6	1.3	10.1	1.5	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.5	0.0	0.2	0.0	0.0	3.1	3.8	2.8	5.8	5.2	3.2	0.3	0.4	0.2	0.2	1.4	3.2	1.1	6.4	0.0	0.3	0.9	0.9	1.5	2.8	0.0	4.9	7.5	6.5	5.3	0.0	1.8	33.1	0.0	102.6	1.5	7.1	0.0	1.5	0.4	1.6	6.9	1.2	0.0	0.0	2.7	0.5	62.2	4.6	9.7	2.7	0.0	26.6	1.1	0.0	8.0	0.0	1.1	3.6	0.0	0.3	1.7	3.3	24.2	0.8	0.0	4.7	0.6	1.9	0.0	0.5	0.9	0.5	5.6	68.4	0.1	0.5	1.6	0.1	0.1	1.2	0.0	5.8	5.7	4.6	10.9	1.2	0.4	23.1	0.9	6.1	2.8	0.2
RIBC1	FLJ32783	ENSG00000158423	"RIB43A domain with coiled-coils 1"	Q8N443	X	53422690-53431120	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 27.5;testis: 39.3"	"Group enriched"	"Detected in many"	5	"Early spermatids: 249.1;Late spermatids: 609.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HeLa: 6.1;T-47d: 7.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA001150			Approved	"Nuclear bodies"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 20: HeLa - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear bodies"		"HPA001150: AB_2666211"	"unprognostic (1.08e-2)"	"prognostic favorable (1.90e-5)"	"unprognostic (1.25e-1)"	"prognostic favorable (9.66e-4)"	"unprognostic (1.11e-1)"	"unprognostic (2.39e-3)"	"unprognostic (9.88e-2)"	"unprognostic (3.97e-4)"	"unprognostic (2.25e-2)"	"unprognostic (7.89e-3)"	"unprognostic (3.79e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.29e-1)"	0.7	3.9	3.2	0.7	3.1	0.6	1.5	2.9	3.4	2.7	10.2	1.1	0.9	2.4	2.9	0.7	27.5	1.4	1.1	3.1	3.9	3.2	0.7	3.3	0.8	7.5	6.5	2.6	1.9	2.6	6.6	0.3	4.7	1.8	0.5	11.4	2.0	1.6	0.7	1.2	0.8	0.6	5.4	0.9	0.9	39.3	3.4	1.7	3.5	0.5	0.6	0.8	0.9	4.8	1.3	3.5	1.3	0.9	0.4	0.9	0.8	0.4	0.2	0.7	0.7	1.3	2.1	1.3	2.3	0.1	2.3	2.4	0.3	0.7	0.9	0.8	2.3	0.8	6.1	0.6	0.2	0.8	1.3	0.3	0.3	2.0	0.5	1.7	0.6	1.0	0.6	1.5	0.5	0.9	1.5	0.7	1.7	0.6	0.9	1.1	0.9	1.0	2.0	0.7	2.9	0.5	3.4	1.2	0.8	4.1	7.8	0.3	0.2	0.3	1.7	1.0	0.5	1.4	1.1	0.7	1.3	0.3	0.6	0.0	0.2	0.0	0.0	0.3	0.6	0.0	0.2	0.5	0.3	0.3	0.1	0.1	0.8	1.2	0.4	0.2	0.5	0.2	3.2	3.1	2.9	3.4	3.1	3.9	7.5	6.5	4.7	5.4	3.4	4.8	0.3	0.0	0.5	1.0	0.2	1.3	2.1	3.7	1.8	2.2	1.7	2.2	1.2	2.8	6.5	0.0	4.2	0.5	0.2	0.3	1.9	1.4	249.1	73.2	1.0	0.8	1.2	0.0	0.2	0.2	0.5	0.9	0.0	1.6	2.5	0.5	0.0	0.7	0.1	1.7	0.3	0.1	10.2	0.6	0.3	609.6	2.5	0.5	1.8	0.0	0.0	5.5	0.0	0.0	0.5	0.5	0.1	1.9	0.0	0.8	0.7	7.2	71.4	11.3	0.0	1.6	1.0	14.2	6.4	0.4	0.9	0.4	0.6	2.1	0.3	0.7
RORC	"NR1F3, RORG, RZRG, TOR"	ENSG00000143365	"RAR related orphan receptor C"	P51449	1	151806071-151831845	"Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 86.2;skeletal muscle: 128.0"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 35.2;Hepatocytes: 47.8;Proximal enterocytes: 32.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebellum: 4.1"	"Immune cell enriched"	"Detected in many"	6	"MAIT T-cell: 50.3"	"Lineage enriched"	"Detected in many"	44	"T-cells: 50.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 23.8;Karpas-707: 11.5;MOLT-4: 6.3;RPMI-8226: 6.0;SK-BR-3: 5.7;T-47d: 9.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA065620			Supported	"Nuclear bodies"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 30: Mammary glandular cells - Lactation"	"Nuclear bodies"		"HPA065620: AB_2685521"	"unprognostic (6.51e-2)"	"unprognostic (7.78e-2)"	"prognostic favorable (1.83e-4)"	"unprognostic (9.20e-2)"	"unprognostic (3.05e-4)"	"unprognostic (6.29e-5)"	"unprognostic (1.13e-3)"	"unprognostic (8.94e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.88e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.42e-1)"	"prognostic favorable (2.94e-5)"	"unprognostic (2.13e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.80e-2)"	2.9	4.9	0.2	1.8	0.1	0.4	7.5	4.1	0.3	6.5	5.2	9.3	11.6	1.9	4.6	5.4	21.2	3.7	11.6	0.2	0.4	18.8	86.2	12.7	0.9	0.9	1.6	0.3	59.2	33.5	18.3	0.0	0.7	15.8	9.2	0.0	41.0	11.0	128.0	24.7	13.9	0.3	0.8	1.3	19.8	10.7	0.4	52.7	26.4	58.8	2.4	3.0	3.4	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.1	0.0	0.0	0.0	23.8	0.0	0.0	2.5	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	11.5	0.0	0.3	6.3	0.0	0.0	0.0	0.0	0.0	0.1	6.0	0.1	0.0	0.0	0.2	0.1	5.7	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	0.0	50.3	0.0	8.0	7.5	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	5.8	1.2	0.2	0.1	4.1	0.3	0.2	0.4	0.9	1.6	0.7	0.8	0.4	0.4	0.1	6.4	6.0	0.3	0.8	2.0	4.4	3.1	3.4	0.0	18.4	9.8	5.9	21.5	5.3	16.5	0.0	0.0	1.8	12.0	35.2	8.3	0.4	15.3	2.6	0.7	9.6	5.3	0.1	7.0	0.0	0.3	17.3	18.9	0.0	0.3	1.8	47.8	0.1	0.0	0.0	20.0	16.2	2.7	0.3	0.9	0.6	0.6	3.6	0.0	0.2	0.0	0.0	0.0	0.0	3.2	16.0	0.4	0.3	5.0	32.9	17.1	10.5	0.0	0.0	4.2	0.5	0.2	0.0	5.0	3.0	0.0	6.8	0.1	15.3	3.5
SAP25	FLJ00248	ENSG00000205307	"Sin3A associated protein 25"	Q8TEE9	7	100572228-100573900	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 47.4"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 70.9;Rod photoreceptor cells: 57.8;Spermatogonia: 86.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HMC-1: 30.4;NB-4: 69.1;OE19: 117.4;U-937: 27.4"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA062610			Approved	"Nuclear bodies"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nuclear bodies"		"HPA062610: AB_2684806"	"unprognostic (1.70e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.09e-5)"	"unprognostic (6.89e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.26e-3)"	"unprognostic (9.96e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.04e-2)"	"unprognostic (6.57e-3)"	"unprognostic (1.71e-2)"	"unprognostic (7.52e-6)"	"unprognostic (7.36e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.18e-3)"	8.8	4.5	18.7	17.9	21.0	28.9	4.7	19.9	26.2	11.1	18.0	5.8	6.5	4.8	0.3	4.4	9.3	5.0	6.6	18.6	20.5	15.8	7.0	14.7	28.6	22.1	19.3	23.2	6.5	1.0	12.9	5.3	20.9	11.0	1.7	13.5	8.3	2.4	3.9	6.1	20.0	2.0	18.5	47.4	5.6	25.4	21.6	17.6	15.8	1.1	8.2	5.0	7.4	24.9	4.0	1.4	2.8	1.6	0.2	0.4	6.4	3.0	0.6	1.9	0.9	3.1	4.1	2.0	1.8	0.0	0.2	4.2	0.5	0.9	0.2	3.9	2.3	3.7	3.6	1.0	0.6	4.2	30.4	0.8	1.9	1.1	0.4	1.5	0.6	8.0	4.7	7.7	0.4	9.2	7.8	69.1	4.3	117.4	1.5	16.7	0.9	3.1	0.3	1.2	1.6	5.0	0.4	3.7	4.5	3.1	5.6	15.8	3.2	2.9	6.1	2.7	2.9	13.1	3.4	1.6	0.9	27.4	3.0	0.9	0.2	0.0	0.2	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	1.1	0.0	0.2	0.3	0.0	0.0	18.7	21.0	19.9	26.2	18.6	20.5	22.1	19.3	20.9	18.5	21.6	24.9	2.2	0.0	4.1	11.1	6.7	0.0	1.3	0.0	1.2	23.7	4.6	5.3	0.0	7.2	1.3	0.0	70.9	2.6	8.7	3.1	0.0	1.9	1.4	2.1	2.0	1.7	0.0	3.4	0.9	0.7	0.7	1.3	4.1	3.2	1.3	6.0	2.5	1.1	3.1	21.9	0.9	2.3	0.0	8.5	0.0	4.6	3.4	10.7	0.0	9.4	6.5	8.0	5.2	2.5	8.2	2.0	1.9	1.2	4.1	2.8	4.9	0.3	0.0	57.8	6.6	1.5	1.8	17.2	86.6	1.5	0.0	3.6	8.2	0.9	1.5	1.8
SBF1	"DENND7A, MTMR5"	ENSG00000100241	"SET binding factor 1"	O95248	22	50445000-50475035	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074004			Supported	"Nuclear bodies"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear bodies"		"HPA074004: AB_2732249"	"unprognostic (4.79e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.87e-2)"	"unprognostic (6.11e-2)"	"prognostic favorable (3.46e-5)"	"unprognostic (2.21e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.42e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.05e-1)"	26.8	32.3	50.8	22.3	57.3	20.6	24.2	31.8	72.4	25.9	9.2	32.9	14.8	29.5	3.2	43.9	27.2	10.6	38.7	70.1	28.5	30.5	23.4	26.8	28.8	52.0	39.2	30.4	48.0	7.1	28.6	8.8	46.5	28.5	4.9	6.5	26.9	11.6	75.7	42.2	38.6	8.8	32.8	35.4	30.1	111.2	44.1	32.7	62.3	14.4	14.7	28.3	27.3	63.5	34.3	28.2	24.0	32.9	24.3	18.6	65.9	23.5	20.1	21.6	17.7	39.0	23.7	78.1	16.7	27.9	23.9	31.4	19.9	28.7	5.3	28.6	76.0	17.6	59.6	50.7	41.7	54.7	26.1	25.0	44.6	28.1	21.0	17.0	14.8	41.6	28.8	20.8	15.0	42.6	54.8	52.4	10.1	26.1	31.7	71.0	45.6	48.3	12.8	27.3	19.1	46.0	36.5	35.5	47.7	10.5	20.7	25.2	25.1	33.9	49.6	24.3	29.7	38.1	13.4	37.6	38.8	22.1	32.7	0.5	1.3	2.1	4.4	1.3	2.4	2.6	3.0	3.5	1.6	1.6	2.2	3.6	1.9	1.9	2.6	5.6	2.6	2.3	50.8	57.3	31.8	72.4	70.1	28.5	52.0	39.2	46.5	32.8	44.1	63.5	5.7	6.4	11.8	10.7	13.7	13.4	4.6	9.3	6.8	15.5	11.3	9.1	7.6	4.3	9.4	3.7	10.4	4.9	21.4	19.9	1.9	7.2	32.8	10.3	8.9	5.6	3.6	8.6	11.3	12.5	7.9	10.6	24.5	11.4	1.3	20.4	5.7	9.1	6.9	11.8	10.9	13.2	10.2	6.9	10.7	21.4	6.5	9.5	5.4	5.6	10.8	6.9	21.6	11.1	31.7	19.9	8.1	6.0	15.6	11.6	16.0	7.7	11.1	10.0	6.6	12.3	11.6	25.5	23.5	21.3	14.6	11.5	19.8	12.2	12.3	10.1
SCRT1	"DKFZp547F072, ZNF898"	ENSG00000261678	"Scratch family transcriptional repressor 1"	Q9BWW7	8	144330565-144336482	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"brain: 64.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 41.2;Early spermatids: 55.6;Excitatory neurons: 10.6;Horizontal cells: 35.3;Inhibitory neurons: 14.2;Late spermatids: 11.2"	"Cancer enriched"	"Detected in single"	5	"glioma: 1.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045265	Uncertain		Supported	"Nuclear bodies"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear bodies"		"HPA045265: AB_10959521"	"unprognostic (7.70e-2)"	"unprognostic (7.97e-2)"	"unprognostic (6.96e-3)"	"unprognostic (6.88e-4)"	"unprognostic (2.43e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.02e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.83e-4)"	"unprognostic (5.02e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.04e-1)"	0.0	0.5	3.4	0.0	4.8	0.0	0.0	12.5	64.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	19.4	0.0	0.0	0.0	0.0	22.9	8.5	0.0	0.3	0.0	3.4	0.0	18.1	0.0	0.0	3.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.4	26.2	0.0	0.0	0.0	0.0	0.0	0.0	23.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	4.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	4.8	12.5	64.2	1.6	19.4	22.9	8.5	18.1	0.1	26.2	23.6	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	41.2	0.0	0.1	1.6	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	55.6	0.0	0.0	0.3	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.3	14.2	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.1	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0
SERF1A	"4F5, FAM2A, H4F5, SERF1, SMAM1"	ENSG00000172058	"Small EDRK-rich factor 1A"	O75920	5	70900669-70918530	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 64.7;testis: 43.7"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 92.1;Cone photoreceptor cells: 25.0;Rod photoreceptor cells: 26.9;Smooth muscle cells: 17.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SiHa: 111.9;SK-MEL-30: 80.5;WM-115: 59.8"									HPA075271			Uncertain	"Nuclear bodies"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nuclear bodies"		"HPA075271: AB_2686740"	"unprognostic (1.14e-1)"	"unprognostic (3.00e-2)"	"unprognostic (9.58e-2)"		"unprognostic (3.07e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.81e-3)"	"unprognostic (1.29e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.83e-3)"	"unprognostic (4.13e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.22e-2)"	"unprognostic (9.53e-2)"	3.9	2.6	10.1	3.2	10.5	5.8	3.3	9.6	30.3	2.4	9.7	3.4	0.5	5.6	38.3	7.5	2.3	10.9	3.8	10.2	10.4	16.2	5.6	6.2	5.7	9.8	9.7	6.4	13.4	13.7	3.7	3.2	9.9	6.1	8.1	64.7	9.5	5.5	3.4	5.5	2.5	10.5	9.0	5.3	8.4	43.7	9.7	0.6	9.5	0.1	0.4	12.5	2.7	10.3	35.9	0.2	5.5	5.6	32.6	22.0	28.3	10.3	14.7	5.0	2.1	1.0	0.3	1.8	57.9	16.4	1.1	9.7	0.8	0.4	24.9	1.3	1.3	17.4	2.2	1.0	0.3	5.6	0.6	1.1	30.6	0.2	0.5	23.5	1.0	0.3	0.2	6.3	0.2	1.6	32.8	28.8	19.7	0.0	0.2	0.2	18.4	13.9	7.1	2.6	38.5	17.3	111.9	17.2	80.5	0.4	50.0	10.6	53.8	28.4	4.3	1.8	0.5	0.5	0.5	27.4	0.5	0.1	59.8	0.1	0.8	10.2	2.9	1.6	2.8	3.5	2.5	5.0	0.2	2.8	2.0	2.1	2.6	3.2	2.6	1.5	3.5	0.6	10.1	10.5	9.6	30.3	10.2	10.4	9.8	9.7	9.9	9.0	9.7	10.3	1.7	0.0	4.2	0.3	1.9	1.9	2.7	2.4	0.6	3.9	1.8	1.3	92.1	2.8	3.2	3.7	25.0	0.3	1.5	2.4	3.9	1.7	2.8	0.8	1.2	8.2	5.4	0.0	0.5	0.5	0.4	6.2	0.0	0.7	2.5	1.5	1.4	0.2	0.5	0.0	0.4	1.0	0.0	0.3	2.1	1.2	2.1	0.5	0.0	0.0	1.3	2.4	0.0	0.0	0.4	1.0	3.2	3.8	1.2	2.3	3.1	1.5	4.2	26.9	0.0	3.1	17.1	3.0	2.0	0.3	2.3	0.1	1.9	1.4	1.8	1.0
SERF1B	"FAM2B, H4F5C"	ENSG00000205572	"Small EDRK-rich factor 1B"	O75920	5	70025247-70043113	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 154.4"	"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 40.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 11.3"									HPA075271			Approved	"Nuclear bodies"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 71: Testis - DNA repair"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nuclear bodies"		"HPA075271: AB_2686740"	"unprognostic (1.00e-1)"	"unprognostic (2.52e-4)"	"unprognostic (2.60e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.32e-1)"	"unprognostic (5.98e-2)"	"unprognostic (4.92e-3)"	"unprognostic (1.48e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.08e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.44e-2)"	"unprognostic (7.82e-2)"	"unprognostic (6.74e-2)"	"unprognostic (3.52e-1)"	27.3	27.0	0.8	1.6	1.3	1.7	30.3	1.3	2.1	34.4	0.3	45.0	0.7	31.9	0.5	28.6	25.5	1.0	44.7	1.5	2.3	36.4	14.9	30.5	2.1	0.8	0.7	27.1	27.7	1.4	38.0	1.0	0.9	30.4	1.2	11.4	25.1	2.1	46.5	22.7	30.8	2.9	0.8	23.3	28.4	154.4	0.7	1.3	33.8	1.2	1.6	28.3	32.4	1.5	2.6	0.7	4.1	6.0	3.8	1.5	1.1	1.0	1.8	1.7	3.7	0.6	3.0	3.1	11.3	1.1	3.8	1.3	2.6	1.9	1.6	8.0	0.9	3.0	1.3	1.6	1.5	0.1	2.9	1.2	5.3	1.9	0.3	1.3	1.7	0.9	1.2	2.5	0.5	0.2	4.7	2.1	3.6	0.0	0.4	2.4	6.3	5.0	1.3	1.5	7.8	5.1	2.7	0.1	3.7	1.8	2.6	1.1	6.3	1.6	1.8	1.0	1.7	2.0	3.4	3.5	1.6	0.2	3.2	0.3	0.2	1.8	4.1	1.5	4.8	3.3	5.9	2.9	2.9	6.3	7.0	4.9	0.5	2.6	1.5	4.6	2.8	1.9	0.8	1.3	1.3	2.1	1.5	2.3	0.8	0.7	0.9	0.8	0.7	1.5	0.4	9.6	2.2	0.0	1.0	0.4	0.7	0.3	1.2	0.1	0.5	0.5	40.3	0.0	3.2	0.0	2.1	0.1	0.4	0.6	1.9	0.2	1.6	0.3	0.7	4.4	0.0	0.4	0.0	0.0	0.1	3.4	0.0	0.2	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.7	1.0	1.8	0.2	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.1	1.1	5.2	1.4	0.0	0.5	8.8	1.6	0.6	0.9	0.6	0.0	0.7	0.1	0.4	0.4
SH3BGRL3		ENSG00000142669	"SH3 domain binding glutamate rich protein like 3"	Q9H299	1	26280086-26281522	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 2516.1;Langerhans cells: 2368.4;Pancreatic endocrine cells: 2492.4;Urothelial cells: 2342.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030848, HPA076219"	Enhanced		Approved	"Nuclear bodies"		NA	NA		41000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nuclear bodies"		"HPA030848: AB_10602398, HPA076219: AB_2686787"	"unprognostic (4.97e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.73e-3)"	"unprognostic (4.95e-2)"	"unprognostic (8.68e-2)"	"unprognostic (4.29e-3)"	"unprognostic (3.16e-1)"	"unprognostic (3.62e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.98e-2)"	"unprognostic (9.55e-2)"	"prognostic unfavorable (2.17e-10)"	"unprognostic (1.66e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.35e-2)"	"unprognostic (4.43e-2)"	221.9	102.0	289.8	423.0	302.9	530.2	141.8	306.0	380.2	135.5	269.7	416.3	161.9	85.8	708.2	368.2	101.4	177.5	120.8	299.4	321.7	115.9	121.6	289.5	404.4	316.2	340.4	66.7	157.4	85.5	83.2	155.4	320.6	82.5	437.9	32.2	139.6	112.3	47.6	305.9	164.7	202.6	297.0	313.1	223.2	26.2	351.0	306.7	82.9	81.0	437.0	424.5	176.3	325.7	501.1	274.9	187.5	265.7	769.3	2090.9	23.2	895.6	1315.0	959.2	611.0	220.3	460.4	120.8	297.9	1963.3	268.2	182.6	108.9	1030.2	642.6	192.0	109.3	976.3	212.1	213.3	604.8	280.1	1447.9	836.8	652.4	912.9	742.0	1115.0	1200.3	244.7	112.2	430.6	1767.3	337.8	182.1	478.2	221.6	434.8	2003.4	341.1	229.0	170.5	762.6	216.7	119.7	189.8	331.2	338.1	374.1	199.3	65.7	431.9	1451.5	1071.0	370.8	1492.9	402.3	135.7	241.6	104.0	2253.9	792.3	532.5	4277.3	7085.6	6427.9	4340.1	6247.2	3228.5	2422.2	3706.5	4249.4	5891.3	2181.2	1591.2	3072.9	7753.8	2344.8	6190.5	3152.1	5092.0	13045.6	289.8	302.9	306.0	380.2	299.4	321.7	316.2	340.4	320.6	297.0	351.0	325.7	445.2	96.1	168.0	9.8	603.5	984.1	995.1	708.3	373.9	17.1	216.7	227.1	7.8	193.0	290.5	367.8	4.2	133.1	1060.9	1614.6	313.1	1108.5	15.8	178.9	410.9	502.9	339.8	220.0	12.9	1031.5	436.1	493.8	388.4	344.0	1017.6	67.2	346.6	121.7	2516.1	16.8	8.2	1430.3	205.4	1796.4	2368.4	52.8	139.1	2209.6	779.1	16.9	1116.8	76.9	1251.3	4.0	20.2	2492.4	1309.6	162.1	397.9	1754.9	391.7	498.6	202.8	16.4	151.2	71.9	336.4	9.1	23.5	788.1	1058.7	227.1	1380.4	99.2	507.5	2342.3
SIRPB2	"dJ776F14.2, PTPN1L, PTPNS1L3"	ENSG00000196209	"Signal regulatory protein beta 2"	Q5JXA9	20	1470741-1491587	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 13.1"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 5.1;Kupffer cells: 20.0;Macrophages: 9.5;Microglial cells: 14.0;monocytes: 8.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"classical monocyte: 51.1;eosinophil: 31.7;intermediate monocyte: 30.4;myeloid DC: 21.1;neutrophil: 69.5;non-classical monocyte: 24.4"	"Group enriched"	"Detected in many"	329	"dendritic cells: 21.1;granulocytes: 69.5;monocytes: 51.1"	"Cell line enhanced"	"Detected in some"		"A-431: 4.7;HBEC3-KT: 4.0;HMC-1: 7.8;hTCEpi: 8.5;HUVEC TERT2: 4.3;THP-1: 7.7;TIME: 3.7;U-937: 8.3"					"Low region specificity"	"Detected in all"			"HPA011548, HPA048032"	Uncertain		Approved	"Nuclear bodies"		NA	NA		250000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nuclear bodies"		"HPA011548: AB_2668514, HPA048032: AB_2680236"	"unprognostic (3.22e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.50e-5)"	"unprognostic (3.59e-3)"	"unprognostic (9.24e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.06e-1)"	5.6	2.4	1.1	12.0	1.2	6.5	1.6	1.3	1.6	1.8	1.8	1.5	0.9	0.9	0.1	1.8	1.6	3.7	1.4	1.1	1.5	1.1	1.8	7.2	7.0	2.7	2.1	0.5	0.7	0.6	0.6	7.5	2.4	0.9	1.7	0.2	1.3	0.6	0.5	0.9	2.0	4.1	1.6	13.1	1.2	0.5	2.7	1.4	0.7	1.8	3.2	3.9	0.9	2.6	4.7	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	1.1	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	7.8	0.0	8.5	0.0	0.2	0.0	4.3	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	7.7	3.7	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	8.3	0.0	3.0	51.1	31.7	0.1	30.4	0.0	0.0	0.0	0.0	21.1	0.1	0.0	0.0	69.5	0.0	24.4	0.6	0.0	18.9	1.1	1.2	1.3	1.6	1.1	1.5	2.7	2.1	2.4	1.6	2.7	2.6	0.0	0.0	1.1	0.0	0.5	0.3	0.9	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.7	0.0	0.4	0.0	0.0	0.6	0.6	0.0	0.1	1.3	0.0	1.4	0.2	5.1	0.0	0.1	0.0	0.0	20.0	3.3	0.0	0.0	9.5	0.0	14.0	8.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.3	0.1	0.7	0.3	0.1	0.0	0.6
SLC27A6	"ACSVL2, FACVL2, FATP6, VLCS-H1"	ENSG00000113396	"Solute carrier family 27 member 6"	Q9Y2P4	5	128538013-129033642	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 24.4;fallopian tube: 21.3;heart muscle: 23.5"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 25.0;Cardiomyocytes: 29.6;Cytotrophoblasts: 54.8;Extravillous trophoblasts: 37.3;Muller glia cells: 33.0;Skeletal myocytes: 18.0;Syncytiotrophoblasts: 27.5"	"Cancer enriched"	"Detected in many"	8	"thyroid cancer: 19.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"BEWO: 43.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA008987	Approved		Approved	"Nuclear bodies"		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear bodies"		"HPA008987: AB_1857065"	"unprognostic (5.39e-5)"	"unprognostic (4.79e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.34e-2)"		"unprognostic (1.01e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.53e-1)"		"unprognostic (2.64e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.54e-2)"	"unprognostic (9.66e-4)"	0.4	24.4	1.8	0.3	2.4	0.1	3.0	3.0	1.4	3.9	0.7	0.9	0.4	4.3	0.2	4.2	21.3	2.7	23.5	1.2	3.6	0.0	0.1	0.8	0.2	9.7	5.2	9.7	0.1	0.0	6.0	6.7	7.5	3.6	1.7	7.4	3.5	0.3	0.4	2.0	1.1	0.8	5.8	0.1	0.5	13.0	5.5	9.6	1.8	0.9	5.7	1.1	2.9	8.4	0.0	0.0	0.1	0.0	0.0	0.0	43.7	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.1	0.9	0.2	0.7	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	3.5	0.0	3.3	2.0	0.0	0.0	2.3	0.0	0.0	0.0	0.3	0.3	4.4	0.0	5.1	0.0	3.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.4	3.0	1.4	1.2	3.6	9.7	5.2	7.5	5.8	5.5	8.4	0.0	0.0	0.0	0.0	0.0	3.2	0.9	0.0	25.0	0.6	0.2	5.5	29.6	0.0	0.0	0.0	0.0	54.8	0.0	0.0	0.0	0.0	13.2	3.8	1.0	0.3	0.0	0.0	0.4	0.0	37.3	2.7	0.0	1.9	0.0	1.7	0.0	0.0	3.8	3.3	4.6	0.0	0.0	0.0	0.4	2.8	0.3	0.2	0.0	0.0	0.0	33.0	0.0	1.0	1.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.9	0.0	18.0	0.3	1.1	1.0	1.8	0.9	27.5	0.0	2.3	0.1	0.1
TBC1D10C	"Carabin, EPI64C, FLJ00332"	ENSG00000175463	"TBC1 domain family member 10C"	Q8IV04	11	67403915-67410089	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 40.4;intestine: 25.6;lymphoid tissue: 58.6"	"Group enriched"	"Detected in many"	4	"B-cells: 109.6;dendritic cells: 144.4;NK-cells: 284.2;T-cells: 147.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 19.0;JURKAT: 27.3;MOLT-4: 47.1;NB-4: 64.7;U-937: 24.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA069743	Enhanced		Approved	"Nuclear bodies"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear bodies"		"HPA069743: AB_2686186"	"prognostic favorable (3.83e-4)"	"prognostic favorable (4.20e-4)"	"unprognostic (9.23e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.28e-3)"	"prognostic favorable (1.86e-5)"	"unprognostic (6.22e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (4.35e-7)"	"unprognostic (1.52e-1)"	"unprognostic (3.88e-2)"	"unprognostic (7.18e-2)"	"unprognostic (3.81e-2)"	2.3	0.7	0.7	25.8	1.2	40.4	1.1	0.4	1.2	1.4	0.8	4.1	5.5	0.9	0.1	2.3	1.9	3.2	0.9	0.6	0.6	2.5	2.6	8.9	56.7	0.9	0.5	0.5	0.8	0.2	0.5	0.8	0.6	1.9	1.5	0.0	3.8	0.7	0.9	1.4	25.6	0.5	0.5	58.6	7.6	0.5	0.7	46.0	7.6	0.6	21.8	3.2	1.7	1.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	8.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	11.7	0.1	1.2	0.0	6.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	27.3	0.1	0.0	0.0	0.3	47.1	64.7	0.0	0.0	0.0	6.6	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	4.5	0.0	0.0	0.1	0.2	0.0	0.4	0.5	12.2	0.0	24.6	0.0	191.0	46.0	270.4	237.7	120.4	169.7	177.3	201.5	208.3	65.6	184.2	206.7	192.0	237.6	148.0	167.0	55.8	286.6	261.6	0.7	1.2	0.4	1.2	0.6	0.6	0.9	0.5	0.6	0.5	0.7	1.1	2.5	6.4	19.5	0.0	109.6	1.1	0.1	0.1	0.6	1.0	1.4	1.9	1.5	2.8	2.5	0.0	0.0	0.2	144.4	0.2	0.0	0.2	0.2	2.4	0.4	1.9	1.2	12.6	0.2	0.0	0.3	2.0	2.0	1.1	23.4	0.1	5.0	1.4	23.7	0.0	0.1	0.0	0.0	16.0	6.9	0.6	0.0	23.1	3.6	1.0	24.5	0.3	284.2	0.0	0.5	0.0	0.0	0.0	40.2	0.1	0.1	1.1	1.3	0.5	0.0	1.3	1.1	0.1	0.2	0.0	1.0	0.4	147.7	0.1	0.1	0.1
THRB	"ERBA-BETA, ERBA2, GRTH, NR1A2, PRTH, THR1, THRB1, THRB2"	ENSG00000151090	"Thyroid hormone receptor beta"	P10828	3	24117153-24495756	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, Deafness, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 199.2;Cone photoreceptor cells: 164.7;Excitatory neurons: 688.0;Inhibitory neurons: 631.3;Oligodendrocyte precursor cells: 329.2"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"amygdala: 7.7;basal ganglia: 15.1;cerebral cortex: 17.6;hippocampal formation: 18.5;white matter: 6.7"	"Group enriched"	"Detected in some"	5	"basophil: 7.2;naive B-cell: 2.2"	"Group enriched"	"Detected in many"	15	"B-cells: 2.2;granulocytes: 7.2"	"Cell line enhanced"	"Detected in many"		"K-562: 45.6;RT4: 32.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002008, CAB002009, HPA061035"	Approved		Supported	"Nuclear bodies"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear bodies"		"CAB002008: , CAB002009: , HPA061035: AB_2684422"	"unprognostic (1.82e-1)"	"unprognostic (4.22e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.20e-6)"	"unprognostic (3.37e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.78e-3)"	"unprognostic (2.95e-2)"	"unprognostic (4.43e-1)"	"unprognostic (2.01e-2)"	"prognostic favorable (9.46e-8)"	"unprognostic (1.32e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.34e-2)"	11.1	4.9	7.7	1.7	15.1	1.0	10.0	0.0	17.6	2.8	0.0	11.7	2.5	7.0	1.8	6.4	3.8	2.2	7.7	18.5	2.0	12.1	20.1	5.0	1.5	0.0	0.0	2.3	9.0	7.3	15.7	4.4	0.0	7.5	8.4	20.1	6.2	7.7	23.6	6.8	3.9	7.0	0.0	5.7	8.3	0.7	1.4	3.6	4.4	27.0	1.4	8.9	4.2	6.7	10.3	3.1	0.6	0.1	17.4	8.8	6.7	0.5	2.1	1.5	3.2	6.7	9.7	0.1	2.5	6.8	1.1	15.4	10.8	3.9	1.0	0.0	6.4	0.0	2.5	8.9	0.5	0.0	0.0	16.0	7.3	0.2	1.2	3.5	0.0	0.0	45.6	0.0	1.5	0.6	0.0	0.0	6.5	0.6	3.4	0.0	0.0	0.0	10.0	32.7	1.7	0.6	16.5	8.9	0.2	4.6	9.7	0.0	0.9	3.9	3.0	0.0	1.9	0.1	0.5	0.0	2.7	0.1	0.3	7.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	2.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.2	7.7	15.1	0.0	17.6	18.5	2.0	0.0	0.0	0.0	0.0	1.4	6.7	3.0	3.2	11.4	199.2	3.3	9.9	29.5	13.2	1.8	17.9	24.5	18.7	11.6	8.6	14.1	23.9	164.7	12.4	0.0	39.9	1.9	2.4	2.3	3.4	0.5	6.0	25.2	3.8	688.0	12.5	23.2	13.7	16.3	5.7	0.0	0.3	7.5	37.7	1.7	0.0	631.3	8.1	10.2	11.3	11.7	2.4	0.6	4.6	1.8	97.4	0.2	11.7	0.0	329.2	32.4	10.3	17.5	2.2	0.1	40.1	4.8	8.1	10.3	21.8	6.6	12.0	7.5	0.3	0.7	5.1	23.9	5.5	1.0	0.4	9.8	81.3
TIGD2		ENSG00000180346	"Tigger transposable element derived 2"	Q4W5G0	4	89111533-89114901	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 25.4"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 15.9;Hepatocytes: 21.0;Syncytiotrophoblasts: 39.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 11.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 11.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054844, HPA071168"	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nuclear bodies"		"HPA054844: AB_2682623, HPA071168: AB_2686353"	"unprognostic (7.11e-2)"	"unprognostic (8.02e-2)"	"prognostic favorable (4.59e-4)"	"unprognostic (3.25e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.47e-2)"	"unprognostic (4.96e-2)"	"unprognostic (9.83e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.94e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (7.02e-4)"	2.8	1.9	1.9	3.2	1.9	2.5	10.4	4.7	2.1	3.9	3.9	3.4	6.8	2.4	4.0	2.7	1.7	2.8	1.6	1.7	2.4	5.4	25.4	3.1	4.5	2.0	2.5	2.1	3.6	7.1	3.5	8.6	2.1	3.8	4.1	13.2	10.7	2.5	1.9	2.4	4.8	1.9	1.8	3.5	4.4	3.7	2.4	5.5	5.6	3.1	4.5	3.0	2.7	2.3	15.2	7.0	7.5	9.0	8.1	6.2	3.3	9.0	11.0	8.5	7.1	14.1	14.4	7.3	4.7	3.6	6.1	4.7	8.2	13.8	11.4	12.7	2.6	8.6	7.7	6.8	24.0	4.0	5.9	15.4	13.4	3.4	12.2	7.9	3.2	9.6	11.1	12.3	10.6	5.8	7.6	4.6	9.0	16.2	2.3	11.5	13.1	10.0	7.4	28.7	35.6	7.2	8.8	27.8	11.5	9.9	9.8	8.1	2.5	10.9	10.1	3.5	6.9	19.7	6.4	5.5	9.6	7.0	9.4	11.7	1.3	0.1	1.9	1.9	0.9	1.2	0.9	1.4	1.5	1.0	0.9	1.4	0.0	2.2	1.0	0.2	1.0	0.9	1.9	1.9	4.7	2.1	1.7	2.4	2.0	2.5	2.1	1.8	2.4	2.3	1.9	0.0	0.5	1.3	1.8	0.3	5.9	1.7	7.4	4.5	4.9	3.3	3.5	7.2	5.5	3.7	10.4	15.9	1.3	1.2	1.9	2.7	1.4	6.3	3.0	2.6	2.4	1.7	1.3	5.7	10.5	1.7	4.6	6.3	0.0	2.8	2.2	21.0	4.9	0.0	1.9	2.9	0.0	2.4	1.1	0.8	1.5	3.5	0.0	0.0	4.3	2.7	1.0	1.5	2.3	3.8	1.9	1.2	2.4	2.3	8.3	10.2	1.5	7.2	0.0	1.5	2.7	2.3	8.0	3.6	0.4	39.0	2.5	2.1	3.2	1.6
TINF2	TIN2	ENSG00000092330	"TERF1 interacting nuclear factor 2"	Q9BSI4	14	24239643-24242674	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 233.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059061, HPA069807"			Enhanced	"Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear bodies"		"HPA059061: AB_2683895, HPA069807: AB_2686203"	"prognostic favorable (4.96e-4)"	"unprognostic (8.58e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.70e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.71e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.04e-3)"	"unprognostic (2.17e-1)"	"unprognostic (4.78e-2)"	"unprognostic (7.44e-2)"	47.2	76.4	17.6	17.3	19.1	20.1	44.0	18.9	23.6	42.2	17.7	40.7	11.5	43.7	21.0	63.2	36.1	12.8	39.4	17.6	18.4	48.5	33.5	44.1	22.7	19.5	18.6	32.2	44.6	233.5	31.9	14.2	19.5	37.9	15.7	12.8	37.6	16.2	45.2	40.8	38.4	19.4	18.8	55.8	41.8	16.3	18.7	29.2	40.7	16.1	26.6	40.9	41.4	20.0	18.4	16.4	23.2	12.2	25.1	18.5	11.8	18.3	23.1	26.3	24.5	7.1	20.0	26.7	10.3	26.1	19.0	17.5	13.2	16.5	16.5	34.1	6.7	16.8	15.1	28.5	21.6	17.9	23.1	20.5	26.0	21.1	20.0	24.5	28.9	25.0	6.7	33.1	21.5	20.0	27.0	8.8	5.4	19.3	20.1	21.9	14.8	19.5	23.7	25.8	14.2	13.2	19.1	18.0	17.0	15.3	12.9	11.4	23.3	12.2	14.9	21.0	14.6	25.2	19.5	15.1	14.8	9.9	18.6	124.6	47.8	113.7	59.7	51.1	48.1	58.7	46.5	56.2	41.1	65.1	48.3	48.4	60.2	63.5	49.3	34.9	61.5	75.8	17.6	19.1	18.9	23.6	17.6	18.4	19.5	18.6	19.5	18.8	18.7	20.0	34.6	16.0	23.0	6.2	54.5	16.8	63.8	35.7	26.7	23.0	18.4	17.7	13.5	15.7	29.3	18.4	8.4	31.8	51.1	19.2	35.2	35.1	8.1	12.8	15.7	31.4	13.1	15.8	4.1	47.2	26.5	28.1	16.8	18.7	40.5	10.0	27.8	16.5	35.5	15.2	4.1	16.3	32.6	30.1	19.7	10.7	23.6	29.9	21.4	7.5	43.3	41.8	72.1	3.5	7.5	40.5	23.8	29.7	31.5	38.9	22.0	25.4	9.5	18.8	26.3	25.8	29.9	24.3	26.2	27.4	25.1	42.3	46.5	29.4	15.6	53.0
TRMT11	"C6orf75, dJ187J11.2, MDS024, TRM11, TRMT11-1"	ENSG00000066651	"TRNA methyltransferase 11 homolog"	Q7Z4G4	6	125986479-126203817	"Metabolic proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030473			Approved	"Nuclear bodies"		Yes	No			"Cluster 30: Non-specific - Translation"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nuclear bodies"		"HPA030473: AB_2673493"	"unprognostic (2.55e-1)"	"unprognostic (6.12e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.62e-2)"	"unprognostic (9.69e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.38e-2)"	"unprognostic (3.54e-2)"	"unprognostic (5.73e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.06e-1)"	8.4	10.2	7.3	8.1	7.5	2.9	11.7	12.9	9.9	9.5	6.6	8.8	12.8	13.5	9.9	8.0	9.7	9.0	10.9	7.3	7.8	13.3	19.8	7.9	10.5	6.7	7.4	12.5	6.4	12.6	13.3	9.4	7.2	9.1	9.4	16.9	8.8	8.5	7.6	6.6	10.7	10.7	5.8	6.8	8.8	7.7	7.2	8.7	12.9	8.8	10.4	9.6	8.9	9.0	17.4	11.0	24.2	11.4	12.9	13.7	16.6	13.1	21.7	15.6	24.3	30.8	19.8	26.0	24.2	8.3	29.1	20.7	26.1	14.3	26.4	19.5	37.6	17.8	20.1	46.2	21.9	29.0	5.4	14.3	15.5	15.9	25.6	22.4	7.6	9.1	44.5	5.3	17.7	22.0	15.3	34.6	20.4	15.4	15.1	9.1	16.3	17.6	22.3	9.8	32.4	16.9	13.9	18.0	36.3	18.0	13.1	28.3	5.4	9.7	10.7	27.3	25.8	13.9	1.3	6.6	23.2	24.5	17.7	1.0	1.6	0.0	5.6	1.3	11.0	7.0	7.9	6.5	3.5	6.0	9.5	8.6	0.5	7.7	0.7	4.3	6.0	3.2	7.3	7.5	12.9	9.9	7.3	7.8	6.7	7.4	7.2	5.8	7.2	9.0	11.0	6.4	22.0	24.8	17.4	13.4	27.8	29.4	23.3	59.5	11.2	13.7	12.2	21.5	26.1	7.3	73.0	18.7	14.9	8.5	19.6	19.2	10.1	13.1	25.5	10.4	9.1	8.4	56.1	16.3	13.7	27.3	27.0	12.3	18.4	20.0	6.8	22.5	7.2	20.2	63.8	11.1	18.3	6.0	3.7	4.7	25.7	7.1	3.6	23.4	11.8	21.1	9.2	31.7	48.5	13.2	15.5	24.5	12.3	22.6	22.6	30.2	24.3	74.7	6.6	21.0	17.2	15.6	9.2	14.3	10.1	14.9	14.7	27.2	13.7	17.9
TTC9	"KIAA0227, TTC9A"	ENSG00000133985	"Tetratricopeptide repeat domain 9"	Q92623	14	70641916-70675366	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 60.1"	"Cell type enhanced"	"Detected in many"		"Pancreatic endocrine cells: 36.0;Respiratory ciliated cells: 38.1;Urothelial cells: 56.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 18.2;Daudi: 15.9;RH-30: 21.3;SK-BR-3: 36.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA079473			Approved	"Nuclear bodies"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear bodies"		"HPA079473: "	"unprognostic (2.37e-2)"	"unprognostic (6.01e-2)"	"unprognostic (9.29e-2)"	"prognostic favorable (1.82e-5)"	"unprognostic (3.81e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.53e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.39e-1)"	"prognostic favorable (2.10e-8)"	"unprognostic (1.22e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.16e-2)"	"unprognostic (9.38e-2)"	1.4	1.2	6.4	4.0	6.8	0.9	3.7	3.3	9.8	5.4	1.5	0.8	0.8	1.2	1.4	60.1	10.2	3.4	2.1	6.4	5.9	2.9	1.1	4.4	9.3	5.7	3.9	0.1	1.5	2.9	3.7	4.0	5.5	2.5	0.8	6.0	12.6	1.6	9.5	5.9	2.5	0.8	3.7	5.7	4.1	0.5	4.3	5.1	4.0	5.2	15.4	4.4	13.7	6.5	18.2	2.1	6.7	0.3	0.0	0.0	7.1	0.3	0.1	0.5	2.2	0.4	8.9	15.9	2.4	0.1	1.5	6.6	5.0	0.6	0.3	0.5	1.9	2.2	0.7	5.2	0.0	0.0	4.4	0.6	1.2	0.0	0.1	0.3	0.0	3.5	0.0	1.4	7.3	9.0	0.4	0.2	3.7	13.0	2.3	3.7	21.3	0.1	11.0	4.1	4.1	2.0	2.0	36.4	0.0	4.0	12.7	0.6	0.0	0.0	3.2	0.0	0.3	0.0	0.2	4.9	0.0	0.4	0.1	0.0	0.0	0.6	0.4	0.3	0.9	0.6	0.7	0.5	0.0	1.2	1.1	0.7	0.8	0.0	1.5	0.0	0.4	0.2	6.4	6.8	3.3	9.8	6.4	5.9	5.7	3.9	5.5	3.7	4.3	6.5	3.8	3.2	7.2	1.3	11.3	1.0	4.7	16.3	1.2	3.8	13.7	10.5	1.8	14.3	24.8	9.2	6.2	24.1	1.5	0.2	1.9	21.0	0.4	8.3	2.3	5.9	1.2	0.0	10.5	5.8	2.5	1.2	4.1	19.1	1.3	15.2	0.4	2.2	2.8	0.0	13.6	0.5	16.2	4.1	0.8	0.7	0.0	2.1	7.2	3.7	3.0	15.8	4.1	9.0	0.7	36.0	0.5	0.0	4.4	13.0	0.0	0.3	38.1	5.4	0.0	0.7	2.1	0.1	2.6	9.0	1.7	7.4	7.6	0.2	0.5	56.9
TYW5	"C2orf60, FLJ37953"	ENSG00000162971	"TRNA-yW synthesizing protein 5"	A2RUC4	2	199928913-199955736	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 123.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028294, HPA045803"	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nuclear bodies"		"HPA028294: AB_2672549, HPA045803: AB_10964878"	"unprognostic (3.44e-3)"	"unprognostic (3.74e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.03e-2)"	"unprognostic (9.22e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.47e-3)"	"unprognostic (9.72e-2)"	"unprognostic (6.55e-3)"	"unprognostic (6.30e-3)"	"unprognostic (9.54e-2)"	"unprognostic (6.98e-3)"	"unprognostic (2.87e-3)"	"unprognostic (8.67e-2)"	"unprognostic (4.46e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.42e-3)"	1.0	2.1	2.7	1.4	2.9	3.6	2.1	4.4	3.9	1.0	2.7	1.3	1.8	1.5	1.9	0.9	1.2	1.0	0.9	2.9	2.6	1.6	2.5	1.4	2.3	2.5	2.5	1.7	1.0	1.6	0.5	1.1	2.6	1.4	1.5	7.0	1.7	1.1	1.8	3.7	2.1	1.1	2.2	2.5	1.6	1.1	2.7	1.2	1.7	0.9	1.5	1.0	0.5	4.0	1.3	1.6	2.0	1.7	1.5	1.8	2.3	1.9	1.2	1.5	1.3	1.8	1.6	1.1	1.2	1.3	1.7	1.7	3.1	1.5	2.2	2.0	1.3	2.1	2.7	2.3	3.6	2.4	1.5	1.9	3.5	0.9	3.1	3.5	1.3	1.5	1.7	1.4	0.9	1.9	1.7	3.9	2.4	1.5	2.6	1.5	1.7	1.3	2.8	1.7	1.7	1.3	1.4	2.8	4.2	3.7	1.4	2.7	1.5	1.4	1.2	1.6	1.5	2.4	2.2	1.0	2.3	2.2	1.6	0.5	0.3	0.6	0.3	0.3	0.3	0.3	0.4	0.4	0.2	0.4	0.5	0.4	0.3	0.3	0.3	0.2	0.4	0.1	2.7	2.9	4.4	3.9	2.9	2.6	2.5	2.5	2.6	2.2	2.7	4.0	6.4	6.4	15.5	17.6	8.4	8.3	14.7	9.7	3.4	24.4	4.5	3.7	5.6	4.3	9.6	12.9	123.0	10.4	8.2	6.0	3.9	8.5	2.6	5.4	5.7	7.8	2.4	7.8	17.7	6.2	9.3	8.7	6.6	5.2	6.3	17.1	10.0	8.9	6.0	8.4	15.8	6.7	12.2	8.5	13.9	1.1	6.2	5.7	7.2	14.0	12.1	39.0	14.4	13.0	27.0	10.0	6.7	5.7	5.5	16.5	20.1	10.6	8.5	33.7	6.6	9.7	10.5	10.5	12.4	5.2	6.0	8.3	9.4	12.3	10.3	17.0
UBAP1L		ENSG00000246922	"Ubiquitin associated protein 1 like"	F5GYI3	15	65092760-65115200	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	5	"brain: 14.5;retina: 26.4"	"Group enriched"	"Detected in many"	5	"Cone photoreceptor cells: 241.8;Rod photoreceptor cells: 167.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 2.5;U-266/70: 1.2"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 15.8"	HPA065334			Uncertain	"Nuclear bodies"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nuclear bodies"		"HPA065334: AB_2685472"	"unprognostic (6.89e-3)"	"unprognostic (2.62e-1)"	"unprognostic (2.66e-3)"	"unprognostic (2.73e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.98e-3)"	"unprognostic (6.59e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.62e-5)"	"unprognostic (6.40e-3)"	"unprognostic (3.11e-6)"	"unprognostic (5.03e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.70e-1)"	"unprognostic (6.11e-3)"	1.2	1.1	8.2	0.3	9.1	0.4	1.3	14.5	13.5	2.9	4.4	1.6	0.2	2.0	0.3	1.1	2.6	0.2	1.0	7.0	10.1	1.2	2.1	1.0	0.4	11.8	7.8	3.4	1.0	0.1	2.1	0.2	10.5	2.0	0.1	26.4	0.8	0.5	2.2	1.2	1.3	0.4	6.1	1.6	0.8	1.7	9.6	0.5	2.1	0.3	0.2	1.6	1.7	11.0	0.0	0.0	0.2	0.7	0.2	0.0	0.6	0.4	0.0	0.2	0.2	0.4	0.1	0.3	0.5	0.0	0.1	0.5	0.4	0.0	0.0	0.6	0.3	0.0	0.4	0.1	0.2	0.3	0.3	0.2	0.3	0.1	0.1	0.5	0.0	0.2	0.2	0.2	0.0	0.1	0.1	0.4	0.2	0.0	0.2	0.5	0.1	0.4	0.0	0.1	0.3	0.2	0.2	0.0	2.5	0.3	0.1	0.3	0.0	0.2	0.1	0.2	0.2	1.2	0.2	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.2	9.1	14.5	13.5	7.0	10.1	11.8	7.8	10.5	6.1	9.6	11.0	2.1	0.0	1.1	6.2	1.0	0.6	1.7	1.2	2.2	35.3	2.5	1.9	5.0	0.0	1.5	3.7	241.8	0.8	2.4	0.3	1.9	0.5	0.6	1.7	1.9	2.3	1.2	0.4	18.4	0.9	0.3	1.4	1.1	1.7	0.0	3.3	1.8	2.0	0.3	3.3	18.3	1.2	2.0	0.6	0.8	1.3	3.4	1.0	1.8	3.7	0.0	21.8	0.0	5.5	19.9	1.0	1.1	3.4	1.4	1.3	3.1	9.9	0.3	167.3	6.6	1.8	2.2	2.0	3.4	0.8	0.9	0.7	1.9	1.5	0.8	0.6
YY2	ZNF631	ENSG00000230797	"YY2 transcription factor"	O15391	X	21855987-21858740	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 5.7"	"Group enriched"	"Detected in many"	6	"Spermatocytes: 23.6;Spermatogonia: 57.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA001119, HPA030335"	Enhanced		Approved	"Nuclear bodies"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 18: U-2197 - ECM organization"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nuclear bodies"		"HPA001119: AB_1858930, HPA030335: AB_2673434"	"unprognostic (1.90e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.75e-2)"	"unprognostic (8.39e-3)"	"unprognostic (3.48e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.78e-4)"	"unprognostic (4.04e-1)"	"unprognostic (9.38e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.05e-1)"	1.2	1.2	0.5	1.1	0.6	0.4	1.0	1.5	0.8	1.2	0.5	0.8	0.4	1.7	1.2	0.9	1.0	0.9	0.7	0.5	0.6	1.0	1.6	0.9	0.7	0.6	0.6	1.7	0.8	0.7	1.3	1.5	0.6	1.2	0.7	0.7	0.9	1.0	0.8	1.2	0.7	1.3	0.5	0.8	0.6	5.7	0.6	0.9	0.9	0.6	0.6	0.8	0.9	0.8	3.2	2.9	1.9	6.2	2.3	1.0	0.2	3.4	2.0	3.8	4.4	2.3	5.1	3.6	1.9	4.5	5.0	1.7	4.2	4.6	6.7	2.6	4.1	1.0	7.5	1.9	4.1	3.9	1.9	1.9	3.4	2.9	4.7	3.0	2.4	1.3	3.8	4.2	6.9	2.2	2.1	4.0	3.6	1.6	3.7	2.0	3.2	5.5	2.1	1.3	1.1	2.7	2.0	1.7	5.7	5.0	3.0	1.3	2.7	7.0	1.4	12.4	4.0	2.8	3.5	2.2	4.6	1.9	5.7	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.2	0.1	0.1	0.2	0.5	0.1	0.0	0.2	0.0	0.2	0.2	0.0	0.5	0.6	1.5	0.8	0.5	0.6	0.6	0.6	0.6	0.5	0.6	0.8	1.8	0.0	2.6	0.0	0.7	0.9	0.9	1.5	0.6	2.7	1.6	1.3	1.0	1.5	0.7	1.8	4.2	2.9	0.4	0.4	0.0	0.9	0.4	1.0	2.1	2.6	1.2	0.4	0.0	0.7	1.4	1.9	0.0	1.0	1.3	4.4	1.4	2.9	2.3	6.7	0.0	0.9	0.0	1.6	0.6	1.4	6.2	1.0	0.0	0.0	3.4	1.5	2.1	0.0	0.0	1.4	0.5	3.8	1.1	1.5	0.7	0.9	0.8	3.3	0.0	2.7	1.4	23.6	57.5	0.7	1.4	2.1	0.8	3.7	0.8	1.1
ZCCHC12	"FLJ16123, PNMA7A, SIZN, SIZN1"	ENSG00000174460	"Zinc finger CCHC-type containing 12"	Q6PEW1	X	118823824-118826968	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 281.2;endometrium 1: 101.5;fallopian tube: 132.2;smooth muscle: 141.6"	"Cell type enhanced"	"Detected in some"		"Inhibitory neurons: 4.6;Spermatogonia: 5.6"	"Cancer enriched"	"Detected in many"	76	"thyroid cancer: 256.3"	"Group enriched"	"Detected in all"	5	"hypothalamus: 281.2;thalamus: 156.5"	"Immune cell enriched"	"Detected in single"	6	"naive CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	7	"T-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 3.9;HEK 293: 10.1;NTERA-2: 3.2;SH-SY5Y: 2.5;SuSa: 2.0"									"HPA031016, HPA034940"	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear bodies"		"HPA031016: AB_2673698, HPA034940: AB_10671098"	"unprognostic (1.29e-1)"	"unprognostic (7.48e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.44e-1)"	"unprognostic (8.36e-3)"	"unprognostic (5.34e-4)"	"unprognostic (9.18e-13)"	"unprognostic (4.14e-3)"	"unprognostic (1.63e-1)"	"prognostic favorable (3.42e-5)"	"unprognostic (1.18e-1)"	0.2	7.7	35.8	0.8	24.5	0.0	0.4	19.4	30.0	32.1	0.4	1.2	0.3	101.5	8.7	0.0	132.2	0.4	0.1	22.2	281.2	0.1	0.1	0.5	0.6	26.5	48.1	3.1	0.1	0.0	26.9	0.0	37.8	0.4	0.4	4.2	0.0	0.5	0.0	0.0	0.9	141.6	12.4	0.2	0.9	0.5	156.5	0.6	3.1	0.0	0.7	0.0	6.1	5.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.3	0.0	0.2	0.0	3.9	0.0	0.1	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.1	3.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	2.5	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	35.8	24.5	19.4	30.0	22.2	281.2	26.5	48.1	37.8	12.4	156.5	5.5	0.2	0.0	0.0	0.7	0.6	0.0	0.1	0.0	0.6	0.9	0.2	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.5	1.2	0.2	1.2	0.0	0.4	0.0	0.0	0.3	0.0	0.9	0.0	0.5	0.0	0.0	0.1	0.0	4.6	0.5	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.0	0.0	1.6	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.8	0.0	0.5	1.4	1.2	5.6	0.1	0.1	0.0	0.7	0.5	0.1	0.0
ZIC2	HPE5	ENSG00000043355	"Zic family member 2"	O95409	13	99981784-99986765	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Disease variant, Holoprosencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	32	"brain: 123.4;choroid plexus: 35.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 28.1;Cone photoreceptor cells: 6.2;Microglial cells: 29.0;Muller glia cells: 10.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 123.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 86.2;HDLM-2: 43.5;HEK 293: 66.1;NTERA-2: 80.5;SCLC-21H: 179.7"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 113.3"	HPA055031			Supported	"Nuclear bodies"		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nuclear bodies"		"HPA055031: AB_2682676"	"unprognostic (6.43e-6)"	"prognostic favorable (2.64e-4)"	"unprognostic (5.73e-2)"	"unprognostic (1.99e-2)"	"unprognostic (4.39e-1)"	"unprognostic (3.12e-2)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (4.66e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.36e-3)"	"unprognostic (7.42e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.26e-1)"	"unprognostic (2.11e-1)"		"unprognostic (5.36e-3)"	0.0	0.2	17.0	0.0	19.0	0.0	0.0	123.4	16.2	0.0	35.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	16.0	10.4	0.1	0.0	0.0	0.0	20.9	14.8	0.0	0.0	0.0	1.2	0.0	22.5	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	8.8	0.0	0.0	1.2	27.1	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.5	4.9	86.2	5.5	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.5	5.8	0.0	7.3	0.0	4.6	0.1	3.9	0.0	0.0	43.5	66.1	6.4	4.0	4.4	0.0	0.0	4.3	0.0	6.2	0.0	3.9	0.4	0.0	2.2	6.5	0.0	0.0	2.9	0.4	34.3	80.5	0.0	2.0	19.8	3.3	0.1	0.4	2.2	179.7	0.0	2.8	0.5	0.0	3.3	4.2	33.5	0.0	20.2	0.0	3.6	5.8	0.6	0.0	0.0	4.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	19.0	123.4	16.2	16.0	10.4	20.9	14.8	22.5	8.8	27.1	11.3	0.2	0.0	0.0	28.1	0.0	0.0	0.0	0.0	0.6	0.3	0.2	0.3	0.7	0.0	0.0	1.8	6.2	0.0	0.0	0.7	0.0	0.0	0.4	0.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	29.0	0.0	10.3	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.1	1.5	0.6	0.4	0.1	0.0	0.0	0.0	0.0	0.0
ZNF221		ENSG00000159905	"Zinc finger protein 221"	Q9UK13	19	43951223-43967709	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											HPA059435	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear bodies"		"HPA059435: AB_2684016"	"unprognostic (2.06e-1)"	"unprognostic (8.35e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.17e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.06e-1)"	0.9	1.2	1.3	0.6	1.5	0.6	1.2	4.8	1.5	1.0	1.0	0.7	0.5	1.1	0.8	0.8	1.3	0.6	1.2	1.1	1.5	1.1	1.1	1.0	0.7	1.1	1.3	1.9	0.7	2.3	0.9	1.3	1.7	1.5	0.8	3.0	0.7	1.1	0.4	1.2	0.8	1.3	0.8	1.0	0.8	1.1	1.5	1.2	1.8	0.7	0.7	1.0	0.7	3.5	1.4	1.2	3.6	2.8	1.2	2.4	1.0	1.5	2.3	1.3	2.0	1.6	0.5	0.0	0.8	1.5	0.9	0.6	1.4	1.0	2.3	0.0	2.9	3.8	5.1	0.6	1.2	0.4	1.6	3.5	0.9	2.2	0.8	2.7	2.4	0.0	0.2	0.0	1.7	0.1	0.0	0.6	3.3	0.5	1.2	0.1	4.0	0.4	0.8	4.6	2.9	2.5	3.0	0.2	0.3	2.1	1.0	3.5	4.1	1.6	3.6	0.8	1.2	1.9	2.6	0.0	0.5	1.5	1.9	0.3	0.1	0.2	0.2	0.2	0.2	0.1	0.3	0.3	0.3	0.2	0.2	0.1	0.3	0.6	0.1	0.3	0.1	0.1	1.3	1.5	4.8	1.5	1.1	1.5	1.1	1.3	1.7	0.8	1.5	3.5	1.4	0.0	2.0	1.0	0.2	0.0	0.1	1.1	0.6	2.8	0.5	0.3	0.7	0.0	0.4	0.0	2.1	0.3	0.2	0.1	0.0	0.4	0.3	0.8	1.8	0.8	0.0	1.3	2.7	0.4	0.2	1.4	1.5	0.8	1.3	1.3	0.7	0.1	0.3	0.0	2.1	0.0	0.0	0.0	0.3	0.5	1.2	0.2	1.8	0.0	0.0	1.3	1.0	2.5	2.6	0.5	0.0	0.4	0.4	0.1	0.0	0.4	0.3	2.3	0.0	0.9	1.1	0.9	0.7	0.7	0.1	0.3	0.4	1.3	0.1	0.4
ZNF226		ENSG00000167380	"Zinc finger protein 226"	Q9NYT6	19	44165073-44178381	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA006145, CAB034353"	Uncertain		Approved	"Nuclear bodies"		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear bodies"		"CAB034353: AB_2219110, HPA006145: AB_10696203"	"unprognostic (1.30e-2)"	"unprognostic (5.53e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.41e-3)"	"unprognostic (1.79e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.29e-2)"	"unprognostic (4.05e-2)"	"prognostic favorable (8.34e-4)"	"unprognostic (4.09e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.46e-1)"	"prognostic favorable (2.37e-5)"	13.5	31.5	14.5	12.2	18.6	11.7	20.5	23.1	20.6	13.4	18.5	14.1	13.8	13.9	25.6	10.6	16.1	16.9	16.5	15.0	18.0	18.5	17.9	12.8	20.2	16.5	16.4	20.1	9.4	21.8	32.9	12.1	18.0	21.2	14.5	31.1	12.4	15.7	10.0	12.7	14.8	12.3	18.0	18.7	16.2	17.2	16.4	20.7	23.8	7.2	15.9	15.1	11.4	26.0	18.6	20.3	22.4	16.5	20.8	33.1	10.1	19.0	42.6	20.9	38.0	14.3	22.5	6.6	23.5	24.5	28.9	10.1	9.9	18.8	25.1	10.6	23.7	26.3	25.8	10.8	18.2	17.1	17.1	37.6	24.3	25.4	50.9	40.2	27.7	19.6	5.6	6.3	40.4	6.1	18.7	7.2	10.9	10.8	15.0	11.2	17.9	13.3	20.5	50.9	16.0	25.5	38.2	13.9	9.1	21.9	22.6	24.6	21.7	19.1	23.4	10.5	22.8	31.0	30.6	19.7	17.4	11.7	20.9	53.8	14.7	10.1	22.1	15.6	25.1	19.8	22.2	21.8	17.9	28.2	25.9	22.9	11.4	26.4	13.6	19.3	26.8	13.4	14.5	18.6	23.1	20.6	15.0	18.0	16.5	16.4	18.0	18.0	16.4	26.0	15.1	16.0	13.8	20.5	19.6	4.0	17.0	48.2	8.6	39.8	14.2	14.7	27.6	14.3	30.9	11.0	27.1	13.5	19.8	13.0	35.2	22.7	20.2	24.4	12.3	17.1	12.1	19.1	13.4	27.7	7.5	15.6	16.3	17.0	11.4	25.2	16.1	24.8	18.0	21.9	14.2	18.5	30.5	16.0	7.4	7.4	19.3	12.1	21.4	9.4	22.9	29.3	36.0	17.1	35.8	26.1	19.3	22.2	7.7	20.4	20.9	47.4	37.1	30.7	6.6	13.6	15.0	15.0	21.8	9.2	5.8	12.9	18.4	36.6	10.6	20.5
ZNF234	"HZF4, ZNF269"	ENSG00000263002	"Zinc finger protein 234"	Q14588	19	44141554-44160313	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA001664	Approved		Approved	"Nuclear bodies"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear bodies"		"HPA001664: AB_1080694"	"unprognostic (9.03e-2)"	"unprognostic (8.56e-2)"	"unprognostic (5.31e-2)"	"unprognostic (4.97e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.96e-1)"	"unprognostic (7.77e-3)"	"unprognostic (2.22e-1)"	"unprognostic (5.07e-2)"	"unprognostic (3.43e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.57e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.31e-2)"	"prognostic favorable (4.34e-5)"	3.5	4.8	2.1	4.0	2.9	0.7	4.8	3.7	3.0	3.6	3.2	3.6	3.7	3.7	2.7	3.0	3.2	3.3	4.5	2.1	2.6	3.7	3.1	3.2	4.7	2.4	2.5	5.2	2.9	4.7	3.5	4.7	3.1	4.0	3.6	5.3	3.6	3.5	3.3	4.4	4.0	4.2	1.8	5.7	3.9	2.1	2.7	4.8	4.2	2.9	5.1	3.3	3.3	4.5	5.1	3.5	8.4	8.0	9.8	9.9	3.8	6.5	4.7	5.0	8.3	4.4	3.1	0.1	4.3	5.9	4.7	3.8	6.4	4.1	6.0	0.0	7.7	10.1	8.1	5.8	4.6	0.0	6.8	5.7	9.1	5.4	6.2	6.9	5.7	0.0	0.6	0.1	7.6	1.6	6.8	2.4	5.6	3.3	3.3	0.0	9.6	1.6	3.1	9.7	4.7	7.8	4.7	3.8	3.4	8.6	4.3	4.1	5.8	9.3	7.6	1.7	6.0	5.2	4.7	0.1	1.0	0.0	7.6	1.4	2.0	3.1	3.6	2.6	3.0	2.2	2.1	2.5	2.4	3.4	3.9	3.8	0.7	4.4	1.8	1.6	1.2	1.7	2.1	2.9	3.7	3.0	2.1	2.6	2.4	2.5	3.1	1.8	2.7	4.5	5.0	0.0	2.0	6.2	4.7	3.1	2.4	3.1	2.8	4.8	2.8	2.8	8.3	0.0	4.7	1.8	2.1	5.8	4.2	2.2	5.9	4.1	11.0	3.2	4.7	4.5	3.6	9.1	5.6	2.0	2.5	6.6	3.6	2.5	3.8	7.5	6.8	0.9	2.8	5.0	4.1	2.8	2.0	2.7	2.8	6.3	6.8	2.3	1.8	8.4	3.4	2.9	10.3	7.5	14.2	2.3	5.0	5.7	0.9	2.4	3.3	2.2	2.1	5.7	6.6	4.7	4.3	4.0	4.8	2.7	2.8	3.1	4.8	7.9	2.2	2.2
ZNF410	"APA-1, APA1"	ENSG00000119725	"Zinc finger protein 410"	Q86VK4	14	73886617-73932521	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 27.7;Excitatory neurons: 22.7;Inhibitory neurons: 23.8;Oligodendrocytes: 31.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002871			Approved	"Nuclear bodies"		Yes	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	"Nuclear bodies"		"HPA002871: AB_1080712"	"unprognostic (5.84e-2)"	"unprognostic (5.04e-2)"	"unprognostic (9.29e-2)"	"unprognostic (6.36e-3)"	"unprognostic (5.86e-4)"	"unprognostic (4.91e-2)"	"unprognostic (2.83e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.19e-1)"	29.0	33.0	26.8	18.7	30.4	57.7	29.4	30.9	33.9	30.0	28.9	30.6	19.0	27.5	43.7	33.4	28.1	22.6	21.0	26.3	28.0	33.0	28.8	27.6	25.6	29.1	27.5	38.7	20.6	27.1	27.0	32.2	29.6	29.5	24.4	22.8	24.4	27.3	21.1	37.6	25.2	28.4	26.7	26.1	25.7	44.7	28.3	29.9	24.6	18.3	30.7	29.1	28.7	37.0	46.7	35.8	42.4	45.2	44.8	39.8	52.4	51.4	56.9	88.2	82.0	37.6	40.1	38.4	21.7	65.7	28.2	42.1	42.9	52.8	83.2	56.2	26.9	36.2	31.6	29.9	67.4	30.6	45.6	37.0	72.4	44.5	83.1	39.5	47.5	43.9	38.2	33.0	43.3	88.6	45.8	51.2	15.5	56.3	41.7	40.7	48.5	24.7	57.0	43.7	39.0	50.3	57.2	52.5	54.6	35.5	48.3	52.2	30.7	62.7	59.0	37.1	47.2	45.2	83.4	48.0	40.1	34.1	53.7	65.9	45.3	74.8	47.5	43.1	51.9	37.7	49.0	49.0	45.6	43.0	42.3	43.5	34.4	60.5	50.1	30.8	46.7	55.9	26.8	30.4	30.9	33.9	26.3	28.0	29.1	27.5	29.6	26.7	28.3	37.0	4.3	0.0	3.1	27.7	10.8	0.6	1.5	1.0	10.8	1.5	2.2	1.7	1.1	0.0	2.9	0.0	4.2	1.8	5.0	1.7	0.0	1.0	3.8	4.7	5.6	2.6	0.0	5.9	22.7	0.9	1.5	5.3	10.7	6.7	10.8	2.9	1.8	0.4	1.2	1.7	23.8	1.1	0.0	2.2	3.1	1.1	1.2	5.4	1.8	18.7	1.1	2.4	2.1	18.1	31.0	1.3	1.4	0.4	13.4	1.0	2.4	0.7	0.2	4.7	0.0	4.0	5.1	3.3	1.9	10.1	1.1	2.6	10.5	4.1	0.8	1.4
ZNF433	FLJ40981	ENSG00000197647	"Zinc finger protein 433"	Q8N7K0	19	12014732-12035741	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 198.4;Late spermatids: 134.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA073724	Enhanced		Approved	"Nuclear bodies"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	"Nuclear bodies"		"HPA073724: AB_2686631"	"unprognostic (3.48e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.90e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.16e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.36e-3)"	"prognostic favorable (8.33e-15)"	"unprognostic (1.06e-2)"	"unprognostic (6.95e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.69e-2)"	4.1	3.8	5.1	2.3	5.2	11.8	7.8	10.9	5.2	5.7	5.3	3.6	2.1	4.9	9.4	6.9	4.7	3.8	5.3	6.1	5.2	14.2	5.3	4.0	3.2	5.2	5.4	5.7	9.2	9.1	4.9	5.1	5.0	6.3	3.6	9.9	7.2	4.7	5.6	9.0	2.5	3.2	4.3	4.6	4.8	27.6	5.1	1.8	9.1	3.9	2.9	4.5	5.3	6.0	5.5	0.4	4.1	11.5	3.9	3.7	6.0	4.8	3.5	5.3	5.6	3.1	1.1	1.7	2.6	4.1	3.6	2.2	0.0	5.3	5.0	0.8	1.4	4.0	1.1	3.4	4.1	3.7	9.0	4.3	4.9	3.7	1.8	3.3	0.0	6.4	1.0	0.8	5.9	2.3	4.9	4.7	1.6	0.1	4.5	2.6	2.8	0.4	7.7	11.3	3.4	2.8	0.0	3.0	2.3	4.4	6.2	5.5	3.4	6.0	2.5	10.3	3.4	8.1	10.6	4.8	1.1	4.2	3.7	6.5	1.1	5.1	1.3	0.9	1.1	1.5	1.2	1.7	4.1	2.6	1.8	2.2	2.0	5.9	1.4	3.9	0.9	1.1	5.1	5.2	10.9	5.2	6.1	5.2	5.2	5.4	5.0	4.3	5.1	6.0	3.8	3.2	2.8	7.5	1.7	1.8	3.4	3.7	1.8	4.9	4.8	4.3	7.2	5.7	4.1	5.5	16.7	10.5	1.7	0.8	7.9	4.2	198.4	7.1	3.8	2.2	0.0	3.6	6.7	3.8	4.5	3.1	3.6	9.5	3.8	3.3	1.4	3.1	6.9	6.7	5.9	0.5	4.1	2.2	1.6	134.4	3.1	1.5	5.4	0.0	0.0	4.7	1.0	10.1	3.7	3.0	1.1	4.1	0.6	2.1	0.0	6.1	6.1	8.1	6.6	1.9	2.9	35.1	5.7	4.5	2.6	3.4	0.9	2.4	0.8	2.5